| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | type I interferon receptor binding | 7.46e-11 | 17 | 179 | 7 | GO:0005132 | |
| GeneOntologyMolecularFunction | calcium channel activity | CACNA1B CACNA1C CACNA2D1 GRIA1 PKD1L2 PKD1L3 PANX3 RYR3 MCOLN2 | 2.49e-06 | 129 | 179 | 9 | GO:0005262 |
| GeneOntologyMolecularFunction | histone H3K9 demethylase activity | 5.83e-06 | 14 | 179 | 4 | GO:0032454 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | CACNA1B CACNA1C CACNA2D1 GRIA1 PKD1L2 PKD1L3 PANX3 RYR3 MCOLN2 | 9.05e-06 | 151 | 179 | 9 | GO:0015085 |
| GeneOntologyMolecularFunction | ethanol binding | 1.39e-05 | 6 | 179 | 3 | GO:0035276 | |
| GeneOntologyMolecularFunction | histone H3K9me2/H3K9me3 demethylase activity | 1.39e-05 | 6 | 179 | 3 | GO:0140684 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 1.73e-05 | 18 | 179 | 4 | GO:0008569 | |
| GeneOntologyMolecularFunction | cytokine activity | 8.96e-05 | 250 | 179 | 10 | GO:0005125 | |
| GeneOntologyMolecularFunction | histone H3 demethylase activity | 1.08e-04 | 28 | 179 | 4 | GO:0141052 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 1.08e-04 | 28 | 179 | 4 | GO:0051959 | |
| GeneOntologyMolecularFunction | histone H3K36 demethylase activity | 1.11e-04 | 11 | 179 | 3 | GO:0051864 | |
| GeneOntologyMolecularFunction | ferric iron binding | 1.11e-04 | 11 | 179 | 3 | GO:0008199 | |
| GeneOntologyMolecularFunction | histone binding | 1.45e-04 | 265 | 179 | 10 | GO:0042393 | |
| GeneOntologyMolecularFunction | histone demethylase activity | 1.63e-04 | 31 | 179 | 4 | GO:0032452 | |
| GeneOntologyMolecularFunction | cytokine receptor binding | IFNA4 IFNA5 IFNA6 IFNA7 IFNA14 IFNA17 IFNA21 JAK1 LIFR CCL3 CCL5 | 1.71e-04 | 324 | 179 | 11 | GO:0005126 |
| GeneOntologyMolecularFunction | protein demethylase activity | 1.85e-04 | 32 | 179 | 4 | GO:0140457 | |
| GeneOntologyMolecularFunction | CCR5 chemokine receptor binding | 1.90e-04 | 13 | 179 | 3 | GO:0031730 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein transferase activity | MKRN4P UBR2 TRIM61 MKRN1 PELI2 PELI1 TRIM34 ZZEF1 TRIP12 TRIM59 KLHL20 LMO7 MIB1 FBXO21 | 2.21e-04 | 512 | 179 | 14 | GO:0019787 |
| GeneOntologyMolecularFunction | histone modifying activity | 2.30e-04 | 229 | 179 | 9 | GO:0140993 | |
| GeneOntologyMolecularFunction | insulin receptor activity | 2.38e-04 | 3 | 179 | 2 | GO:0005009 | |
| GeneOntologyMolecularFunction | ribonucleoside-diphosphate reductase activity | 2.38e-04 | 3 | 179 | 2 | GO:0061731 | |
| GeneOntologyMolecularFunction | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor | 2.38e-04 | 3 | 179 | 2 | GO:0004748 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | CACNA1B CACNA1C CACNA2D1 GRIA1 PKD1L2 PKD1L3 PANX3 RYR3 CHRND BSND KCNQ5 MCOLN2 GABRA4 | 2.65e-04 | 459 | 179 | 13 | GO:0005216 |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | CACNA1B CACNA1C CACNA2D1 GRIA1 PKD1L2 PKD1L3 PANX3 RYR3 CHRND KCNQ5 MCOLN2 | 2.79e-04 | 343 | 179 | 11 | GO:0005261 |
| GeneOntologyMolecularFunction | channel activity | CACNA1B CACNA1C CACNA2D1 GRIA1 PKD1L2 PKD1L3 PANX3 RYR3 CHRND BSND SLC12A2 KCNQ5 MCOLN2 GABRA4 | 2.85e-04 | 525 | 179 | 14 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | CACNA1B CACNA1C CACNA2D1 GRIA1 PKD1L2 PKD1L3 PANX3 RYR3 CHRND BSND SLC12A2 KCNQ5 MCOLN2 GABRA4 | 2.91e-04 | 526 | 179 | 14 | GO:0022803 |
| GeneOntologyMolecularFunction | aminoacyltransferase activity | MKRN4P UBR2 TRIM61 MKRN1 PELI2 PELI1 TRIM34 ZZEF1 TRIP12 TRIM59 KLHL20 LMO7 MIB1 FBXO21 | 3.26e-04 | 532 | 179 | 14 | GO:0016755 |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 3.27e-04 | 37 | 179 | 4 | GO:0045505 | |
| GeneOntologyMolecularFunction | ubiquitin-protein transferase activity | MKRN4P UBR2 TRIM61 MKRN1 PELI2 PELI1 TRIM34 TRIP12 TRIM59 KLHL20 LMO7 MIB1 FBXO21 | 3.54e-04 | 473 | 179 | 13 | GO:0004842 |
| GeneOntologyMolecularFunction | microtubule motor activity | 4.14e-04 | 70 | 179 | 5 | GO:0003777 | |
| GeneOntologyMolecularFunction | protein phosphatase binding | 6.29e-04 | 210 | 179 | 8 | GO:0019903 | |
| GeneOntologyMolecularFunction | demethylase activity | 6.41e-04 | 44 | 179 | 4 | GO:0032451 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 6.86e-04 | 118 | 179 | 6 | GO:0003774 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in cardiac muscle cell action potential | 7.85e-04 | 5 | 179 | 2 | GO:0086007 | |
| GeneOntologyMolecularFunction | insulin binding | 7.85e-04 | 5 | 179 | 2 | GO:0043559 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor | 7.85e-04 | 5 | 179 | 2 | GO:0016728 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein ligase activity | MKRN4P UBR2 TRIM61 MKRN1 PELI2 PELI1 TRIM34 ZZEF1 TRIP12 TRIM59 MIB1 | 9.60e-04 | 398 | 179 | 11 | GO:0061659 |
| GeneOntologyMolecularFunction | chromatin binding | MKRN4P SOX15 VRK1 ZNF609 EED MKRN1 PHF8 CBFA2T3 TRIM66 KDM4D PBRM1 SUPT6H CHD5 PRKCB SOX14 NKAP | 1.03e-03 | 739 | 179 | 16 | GO:0003682 |
| GeneOntologyMolecularFunction | methylated histone binding | 1.06e-03 | 86 | 179 | 5 | GO:0035064 | |
| GeneOntologyMolecularFunction | phospholipase activator activity | 1.10e-03 | 23 | 179 | 3 | GO:0016004 | |
| GeneOntologyMolecularFunction | zinc ion binding | UBR2 USP13 TRIM61 TRIM34 CPE PHF8 ZZEF1 TRIP12 TRIM59 ADH1A ADH1B ADH1C TRIM66 MIB1 PRKCB ENPP5 DNAJC24 KDM4A | 1.11e-03 | 891 | 179 | 18 | GO:0008270 |
| GeneOntologyMolecularFunction | beta-N-acetylhexosaminidase activity | 1.17e-03 | 6 | 179 | 2 | GO:0004563 | |
| GeneOntologyMolecularFunction | methylation-dependent protein binding | 1.18e-03 | 88 | 179 | 5 | GO:0140034 | |
| GeneOntologyMolecularFunction | all-trans-retinol dehydrogenase (NAD+) activity | 1.25e-03 | 24 | 179 | 3 | GO:0004745 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NAD+) activity | 1.58e-03 | 26 | 179 | 3 | GO:0004022 | |
| GeneOntologyMolecularFunction | acyltransferase activity | MKRN4P UBR2 TRIM61 MKRN1 PELI2 PELI1 TRIM34 ZZEF1 TRIP12 TRIM59 KLHL20 LMO7 HHAT MIB1 BRD1 FBXO21 | 1.69e-03 | 775 | 179 | 16 | GO:0016746 |
| GeneOntologyMolecularFunction | lipase activator activity | 1.77e-03 | 27 | 179 | 3 | GO:0060229 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase activity | 1.99e-03 | 145 | 179 | 6 | GO:0004713 | |
| GeneOntologyMolecularFunction | ubiquitin protein ligase activity | MKRN4P UBR2 TRIM61 MKRN1 PELI2 PELI1 TRIM34 TRIP12 TRIM59 MIB1 | 1.99e-03 | 372 | 179 | 10 | GO:0061630 |
| GeneOntologyMolecularFunction | alcohol binding | 2.26e-03 | 102 | 179 | 5 | GO:0043178 | |
| GeneOntologyMolecularFunction | transition metal ion binding | UBR2 USP13 TRIM61 TRIM34 CPE PHF8 RRM2 ZZEF1 TRIP12 TRIM59 ADH1A ADH1B ADH1C TRIM66 TH MIB1 PRKCB ENPP5 DNAJC24 FTL KDM4A | 2.30e-03 | 1189 | 179 | 21 | GO:0046914 |
| GeneOntologyMolecularFunction | alcohol dehydrogenase [NAD(P)+] activity | 2.41e-03 | 30 | 179 | 3 | GO:0018455 | |
| GeneOntologyMolecularFunction | ferrous iron binding | 2.41e-03 | 30 | 179 | 3 | GO:0008198 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 2.65e-03 | 31 | 179 | 3 | GO:0099604 | |
| GeneOntologyMolecularFunction | phosphatase binding | 2.69e-03 | 264 | 179 | 8 | GO:0019902 | |
| GeneOntologyMolecularFunction | 2-oxoglutarate-dependent dioxygenase activity | 2.76e-03 | 65 | 179 | 4 | GO:0016706 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | 2.76e-03 | 65 | 179 | 4 | GO:0004714 | |
| GeneOntologyMolecularFunction | protein kinase activity | VRK1 FLT4 INSR JAK1 TTBK1 IGF1R GUCY2C PRKCB CCL3 CCL5 POMK STK24 EPHA1 | 3.02e-03 | 600 | 179 | 13 | GO:0004672 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | CACNA1B CACNA1C CACNA2D1 GRIA1 PKD1L2 PKD1L3 PANX3 RYR3 SLC12A2 KCNQ5 MCOLN2 | 3.25e-03 | 465 | 179 | 11 | GO:0046873 |
| GeneOntologyMolecularFunction | gated channel activity | CACNA1B CACNA1C CACNA2D1 GRIA1 RYR3 CHRND KCNQ5 MCOLN2 GABRA4 | 3.26e-03 | 334 | 179 | 9 | GO:0022836 |
| GeneOntologyMolecularFunction | ATP-dependent activity | DHX36 HSP90B1 ABCC4 MYO1A DNAH14 IQCA1L CHD5 DNAH17 DSCC1 DNA2 KIF13A DNAH9 DYNC1H1 | 3.67e-03 | 614 | 179 | 13 | GO:0140657 |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 4.63e-03 | 75 | 179 | 4 | GO:0098960 | |
| GeneOntologyMolecularFunction | CCR1 chemokine receptor binding | 4.97e-03 | 12 | 179 | 2 | GO:0031726 | |
| GeneOntologyMolecularFunction | histone H3 kinase activity | 4.97e-03 | 12 | 179 | 2 | GO:0140996 | |
| GeneOntologyBiologicalProcess | response to dsRNA | DHX36 GRIA1 PELI1 IFNA4 IFNA5 IFNA6 IFNA7 IFNA14 IFNA17 IFNA21 | 1.62e-10 | 63 | 179 | 10 | GO:0043331 |
| GeneOntologyBiologicalProcess | positive regulation of peptidyl-serine phosphorylation of STAT protein | 3.46e-10 | 21 | 179 | 7 | GO:0033141 | |
| GeneOntologyBiologicalProcess | regulation of peptidyl-serine phosphorylation of STAT protein | 1.01e-09 | 24 | 179 | 7 | GO:0033139 | |
| GeneOntologyBiologicalProcess | natural killer cell activation involved in immune response | 2.52e-09 | 42 | 179 | 8 | GO:0002323 | |
| GeneOntologyBiologicalProcess | serine phosphorylation of STAT protein | 3.35e-09 | 28 | 179 | 7 | GO:0042501 | |
| GeneOntologyBiologicalProcess | response to exogenous dsRNA | 2.36e-08 | 55 | 179 | 8 | GO:0043330 | |
| GeneOntologyBiologicalProcess | acetaldehyde biosynthetic process | 6.43e-07 | 3 | 179 | 3 | GO:0046186 | |
| GeneOntologyBiologicalProcess | type I interferon-mediated signaling pathway | 7.49e-07 | 85 | 179 | 8 | GO:0060337 | |
| GeneOntologyBiologicalProcess | cellular response to type I interferon | 8.20e-07 | 86 | 179 | 8 | GO:0071357 | |
| GeneOntologyBiologicalProcess | cellular response to virus | 1.16e-06 | 90 | 179 | 8 | GO:0098586 | |
| GeneOntologyBiologicalProcess | regulation of defense response to virus by host | 1.21e-06 | 63 | 179 | 7 | GO:0050691 | |
| GeneOntologyBiologicalProcess | peptidyl-amino acid modification | IL12RB2 VRK1 FLT4 OXR1 DPY19L1 INSR PPIL6 APOA1 ZZEF1 IFNA4 IFNA5 IFNA6 IFNA7 IFNA14 IFNA17 IFNA21 JAK1 TTBK1 IGF1R HHAT PRKCB DNAJC24 CCL5 MVP EPHA1 | 1.22e-06 | 976 | 179 | 25 | GO:0018193 |
| GeneOntologyBiologicalProcess | response to type I interferon | 1.38e-06 | 92 | 179 | 8 | GO:0034340 | |
| GeneOntologyBiologicalProcess | regulation of receptor signaling pathway via STAT | 4.49e-06 | 143 | 179 | 9 | GO:1904892 | |
| GeneOntologyBiologicalProcess | interferon-mediated signaling pathway | 6.07e-06 | 112 | 179 | 8 | GO:0140888 | |
| GeneOntologyBiologicalProcess | acetaldehyde metabolic process | 6.35e-06 | 5 | 179 | 3 | GO:0006117 | |
| GeneOntologyBiologicalProcess | cell surface receptor signaling pathway via JAK-STAT | 9.36e-06 | 198 | 179 | 10 | GO:0007259 | |
| GeneOntologyBiologicalProcess | lymphocyte activation involved in immune response | DOCK10 IFNA4 IFNA5 IFNA6 IFNA7 IFNA14 IFNA17 IFNA21 JAK1 FCGR3A SUPT6H | 1.28e-05 | 251 | 179 | 11 | GO:0002285 |
| GeneOntologyBiologicalProcess | natural killer cell activation | 1.29e-05 | 124 | 179 | 8 | GO:0030101 | |
| GeneOntologyBiologicalProcess | B cell proliferation | 1.29e-05 | 124 | 179 | 8 | GO:0042100 | |
| GeneOntologyBiologicalProcess | regulation of defense response to virus | 1.34e-05 | 90 | 179 | 7 | GO:0050688 | |
| GeneOntologyBiologicalProcess | regulation of receptor signaling pathway via JAK-STAT | 1.36e-05 | 125 | 179 | 8 | GO:0046425 | |
| GeneOntologyBiologicalProcess | cell surface receptor signaling pathway via STAT | 1.99e-05 | 216 | 179 | 10 | GO:0097696 | |
| GeneOntologyBiologicalProcess | positive regulation of peptidyl-serine phosphorylation | 2.85e-05 | 101 | 179 | 7 | GO:0033138 | |
| GeneOntologyBiologicalProcess | response to organic cyclic compound | CACNA1B CACNA1C DHX36 NRIP1 HSP90B1 GRIA1 PELI1 IFNA4 IFNA5 IFNA6 IFNA7 RYR3 IFNA14 IFNA17 ADH1A IFNA21 ADH1B ADH1C TH IGF1R PRKCB CCL3 PYGM | 4.03e-05 | 1048 | 179 | 23 | GO:0014070 |
| GeneOntologyBiologicalProcess | T cell activation involved in immune response | 4.61e-05 | 148 | 179 | 8 | GO:0002286 | |
| GeneOntologyBiologicalProcess | leukocyte activation involved in immune response | DOCK10 IFNA4 IFNA5 IFNA6 IFNA7 IFNA14 IFNA17 IFNA21 JAK1 FCGR3A SUPT6H CCL3 | 7.80e-05 | 361 | 179 | 12 | GO:0002366 |
| GeneOntologyBiologicalProcess | cell activation involved in immune response | DOCK10 IFNA4 IFNA5 IFNA6 IFNA7 IFNA14 IFNA17 IFNA21 JAK1 FCGR3A SUPT6H CCL3 | 8.66e-05 | 365 | 179 | 12 | GO:0002263 |
| GeneOntologyBiologicalProcess | response to testosterone | 9.53e-05 | 53 | 179 | 5 | GO:0033574 | |
| GeneOntologyBiologicalProcess | response to nitrogen compound | CACNA1B DHX36 UBR2 CACNA2D1 USP13 HSP90B1 INSR GRIA1 PELI1 CHRM1 IFNA4 IFNA5 IFNA6 IFNA7 RYR3 IFNA14 CHRND IFNA17 IFNA21 JAK1 RHOQ TH IGF1R PRKCB PYGM | 1.08e-04 | 1272 | 179 | 25 | GO:1901698 |
| GeneOntologyBiologicalProcess | cytokine-mediated signaling pathway | IL12RB2 EED APOA1 IFNA4 IFNA5 IFNA6 IFNA7 IFNA14 IFNA17 IFNA21 JAK1 LIFR CTR9 CCL3 CCL5 | 1.61e-04 | 577 | 179 | 15 | GO:0019221 |
| GeneOntologyBiologicalProcess | post-translational protein modification | MKRN4P UBR2 USP13 DCAF6 TRIM61 MKRN1 PELI2 PELI1 TRIM34 KCTD21 ZZEF1 DCUN1D4 TRIP12 TRIM59 KLHL20 LMO7 MIB1 PRKCB KLHL12 DSCC1 MAGEC2 MAD2L1 | 1.62e-04 | 1074 | 179 | 22 | GO:0043687 |
| GeneOntologyBiologicalProcess | regulation of peptidyl-serine phosphorylation | 1.97e-04 | 137 | 179 | 7 | GO:0033135 | |
| GeneOntologyBiologicalProcess | B cell activation | DOCK10 PELI1 IFNA4 IFNA5 IFNA6 IFNA7 IFNA14 IFNA17 IFNA21 SUPT6H PRKCB | 2.02e-04 | 341 | 179 | 11 | GO:0042113 |
| GeneOntologyBiologicalProcess | protein ubiquitination | MKRN4P UBR2 DCAF6 TRIM61 MKRN1 PELI2 PELI1 TRIM34 KCTD21 ZZEF1 TRIP12 TRIM59 KLHL20 LMO7 MIB1 KLHL12 MAGEC2 MAD2L1 | 2.55e-04 | 811 | 179 | 18 | GO:0016567 |
| GeneOntologyBiologicalProcess | protein modification by small protein conjugation | MKRN4P UBR2 DCAF6 TRIM61 MKRN1 PELI2 PELI1 TRIM34 KCTD21 ZZEF1 DCUN1D4 TRIP12 TRIM59 KLHL20 LMO7 MIB1 KLHL12 MAGEC2 MAD2L1 | 2.91e-04 | 893 | 179 | 19 | GO:0032446 |
| GeneOntologyBiologicalProcess | peptidyl-serine phosphorylation | VRK1 IFNA4 IFNA5 IFNA6 IFNA7 IFNA14 IFNA17 IFNA21 TTBK1 PRKCB | 3.63e-04 | 307 | 179 | 10 | GO:0018105 |
| GeneOntologyBiologicalProcess | B cell differentiation | 3.81e-04 | 201 | 179 | 8 | GO:0030183 | |
| GeneOntologyBiologicalProcess | behavioral response to ethanol | 4.00e-04 | 17 | 179 | 3 | GO:0048149 | |
| GeneOntologyBiologicalProcess | ethanol catabolic process | 4.00e-04 | 17 | 179 | 3 | GO:0006068 | |
| GeneOntologyBiologicalProcess | ethanol metabolic process | 4.76e-04 | 18 | 179 | 3 | GO:0006067 | |
| GeneOntologyBiologicalProcess | peptidyl-serine modification | VRK1 IFNA4 IFNA5 IFNA6 IFNA7 IFNA14 IFNA17 IFNA21 TTBK1 PRKCB | 4.91e-04 | 319 | 179 | 10 | GO:0018209 |
| GeneOntologyBiologicalProcess | protein modification by small protein conjugation or removal | MKRN4P UBR2 USP13 DCAF6 TRIM61 MKRN1 PELI2 PELI1 TRIM34 KCTD21 ZZEF1 DCUN1D4 TRIP12 TRIM59 KLHL20 LMO7 MIB1 KLHL12 MAGEC2 MAD2L1 | 4.98e-04 | 1009 | 179 | 20 | GO:0070647 |
| GeneOntologyBiologicalProcess | peptidyl-tyrosine phosphorylation | 5.95e-04 | 327 | 179 | 10 | GO:0018108 | |
| GeneOntologyBiologicalProcess | peptidyl-tyrosine modification | 6.23e-04 | 329 | 179 | 10 | GO:0018212 | |
| GeneOntologyCellularComponent | beta-N-acetylhexosaminidase complex | 7.29e-05 | 2 | 179 | 2 | GO:1905379 | |
| GeneOntologyCellularComponent | ribonucleoside-diphosphate reductase complex | 2.18e-04 | 3 | 179 | 2 | GO:0005971 | |
| GeneOntologyCellularComponent | somatodendritic compartment | CACNA1B CACNA1C DHX36 MYO1A LZTS3 MAP6 FAT3 INSR DOCK10 GRIA1 CPE NECTIN3 RRM1 CHRM1 KLHL20 TH TTBK1 IGF1R SLC12A2 BRD1 DYNC1H1 PCMT1 GABRA4 | 3.43e-04 | 1228 | 179 | 23 | GO:0036477 |
| GeneOntologyCellularComponent | insulin receptor complex | 4.33e-04 | 4 | 179 | 2 | GO:0005899 | |
| MousePheno | enhanced behavioral response to alcohol | 2.21e-05 | 16 | 152 | 4 | MP:0009751 | |
| MousePheno | abnormal ethanol metabolism | 2.46e-05 | 6 | 152 | 3 | MP:0005443 | |
| MousePheno | abnormal retinol metabolism | 4.27e-05 | 7 | 152 | 3 | MP:0005444 | |
| Domain | Interferon | 1.05e-10 | 17 | 176 | 7 | PF00143 | |
| Domain | INTERFERON_A_B_D | 1.05e-10 | 17 | 176 | 7 | PS00252 | |
| Domain | Interferon_alpha/beta/delta | 1.05e-10 | 17 | 176 | 7 | IPR000471 | |
| Domain | IFabd | 1.05e-10 | 17 | 176 | 7 | SM00076 | |
| Domain | - | 4.16e-07 | 50 | 176 | 7 | 1.20.1250.10 | |
| Domain | 4_helix_cytokine-like_core | 4.71e-07 | 74 | 176 | 8 | IPR009079 | |
| Domain | 4_helix_cytokine_core | 4.78e-07 | 51 | 176 | 7 | IPR012351 | |
| Domain | ADH_Zn_CS | 4.45e-05 | 8 | 176 | 3 | IPR002328 | |
| Domain | ADH_ZINC | 4.45e-05 | 8 | 176 | 3 | PS00059 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 4.97e-05 | 138 | 176 | 8 | IPR001245 | |
| Domain | JmjC | 6.99e-05 | 24 | 176 | 4 | PF02373 | |
| Domain | Glycohydro_20b2 | 8.83e-05 | 2 | 176 | 2 | PF14845 | |
| Domain | - | 8.83e-05 | 2 | 176 | 2 | 3.30.379.10 | |
| Domain | Beta_hexosaminidase_sua/sub | 8.83e-05 | 2 | 176 | 2 | IPR025705 | |
| Domain | HEX_eukaryotic_N | 8.83e-05 | 2 | 176 | 2 | IPR029019 | |
| Domain | Chitobiase/Hex_dom_2-like | 8.83e-05 | 2 | 176 | 2 | IPR029018 | |
| Domain | JmjN | 9.40e-05 | 10 | 176 | 3 | SM00545 | |
| Domain | JmjN | 9.40e-05 | 10 | 176 | 3 | PF02375 | |
| Domain | JMJN | 9.40e-05 | 10 | 176 | 3 | PS51183 | |
| Domain | JmjN | 9.40e-05 | 10 | 176 | 3 | IPR003349 | |
| Domain | PKD_channel | 1.28e-04 | 11 | 176 | 3 | PF08016 | |
| Domain | PKD1_2_channel | 1.28e-04 | 11 | 176 | 3 | IPR013122 | |
| Domain | PHD | 1.96e-04 | 89 | 176 | 6 | SM00249 | |
| Domain | Znf_PHD | 2.21e-04 | 91 | 176 | 6 | IPR001965 | |
| Domain | Pkinase_Tyr | 2.23e-04 | 129 | 176 | 7 | PF07714 | |
| Domain | JMJC | 2.23e-04 | 32 | 176 | 4 | PS51184 | |
| Domain | JmjC_dom | 2.23e-04 | 32 | 176 | 4 | IPR003347 | |
| Domain | JmjC | 2.52e-04 | 33 | 176 | 4 | SM00558 | |
| Domain | Glyco_hydro_20_cat | 2.63e-04 | 3 | 176 | 2 | IPR015883 | |
| Domain | Glyco_hydro_20 | 2.63e-04 | 3 | 176 | 2 | PF00728 | |
| Domain | Pellino | 2.63e-04 | 3 | 176 | 2 | PF04710 | |
| Domain | Tyr_kinase_insulin-like_rcpt | 2.63e-04 | 3 | 176 | 2 | IPR016246 | |
| Domain | Pellino_fam | 2.63e-04 | 3 | 176 | 2 | IPR006800 | |
| Domain | Dynein_heavy_chain_D4_dom | 2.77e-04 | 14 | 176 | 3 | IPR024317 | |
| Domain | Dynein_HC_stalk | 2.77e-04 | 14 | 176 | 3 | IPR024743 | |
| Domain | MT | 2.77e-04 | 14 | 176 | 3 | PF12777 | |
| Domain | AAA_8 | 2.77e-04 | 14 | 176 | 3 | PF12780 | |
| Domain | ZF_PHD_2 | 2.79e-04 | 95 | 176 | 6 | PS50016 | |
| Domain | ZF_PHD_1 | 2.96e-04 | 96 | 176 | 6 | PS01359 | |
| Domain | - | UBR2 USP13 TRIM61 MKRN1 TRIM34 PHF8 TRIM59 TRIM66 CHD5 MIB1 KDM4A BRD1 KDM4B | 3.44e-04 | 449 | 176 | 13 | 3.30.40.10 |
| Domain | DHC_fam | 3.44e-04 | 15 | 176 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 3.44e-04 | 15 | 176 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 3.44e-04 | 15 | 176 | 3 | IPR004273 | |
| Domain | PKS_ER | 4.21e-04 | 16 | 176 | 3 | IPR020843 | |
| Domain | ADH_N | 4.21e-04 | 16 | 176 | 3 | PF08240 | |
| Domain | PKS_ER | 4.21e-04 | 16 | 176 | 3 | SM00829 | |
| Domain | ADH_N | 4.21e-04 | 16 | 176 | 3 | IPR013154 | |
| Domain | Znf_RING/FYVE/PHD | UBR2 USP13 TRIM61 MKRN1 TRIM34 PHF8 TRIM59 TRIM66 CHD5 MIB1 KDM4A BRD1 KDM4B | 4.24e-04 | 459 | 176 | 13 | IPR013083 |
| Domain | Adenylate_cyclase-assoc_CAP_C | 5.23e-04 | 4 | 176 | 2 | IPR013912 | |
| Domain | - | 6.05e-04 | 18 | 176 | 3 | 3.90.180.10 | |
| Domain | Furin_repeat | 6.05e-04 | 18 | 176 | 3 | IPR006212 | |
| Domain | FU | 6.05e-04 | 18 | 176 | 3 | SM00261 | |
| Domain | PHD | 7.11e-04 | 75 | 176 | 5 | PF00628 | |
| Domain | ADH_zinc_N | 7.13e-04 | 19 | 176 | 3 | PF00107 | |
| Domain | ADH_SF_Zn-type | 7.13e-04 | 19 | 176 | 3 | IPR002085 | |
| Domain | ADH_C | 7.13e-04 | 19 | 176 | 3 | IPR013149 | |
| Domain | CAP/MinC_C | 8.67e-04 | 5 | 176 | 2 | IPR016098 | |
| Domain | CARP_motif | 8.67e-04 | 5 | 176 | 2 | IPR006599 | |
| Domain | - | 8.67e-04 | 5 | 176 | 2 | 2.160.20.70 | |
| Domain | C-CAP_CF_C-like | 8.67e-04 | 5 | 176 | 2 | IPR017901 | |
| Domain | CARP | 8.67e-04 | 5 | 176 | 2 | SM00673 | |
| Domain | C_CAP_COFACTOR_C | 8.67e-04 | 5 | 176 | 2 | PS51329 | |
| Domain | EPHD | 1.11e-03 | 22 | 176 | 3 | PS51805 | |
| Domain | GroES-like | 1.44e-03 | 24 | 176 | 3 | IPR011032 | |
| Domain | Tyr_kinase_cat_dom | 1.46e-03 | 88 | 176 | 5 | IPR020635 | |
| Domain | TyrKc | 1.46e-03 | 88 | 176 | 5 | SM00219 | |
| Domain | - | 1.79e-03 | 55 | 176 | 4 | 1.10.30.10 | |
| Domain | Recep_L_domain | 1.80e-03 | 7 | 176 | 2 | PF01030 | |
| Domain | Ca_chan_IQ | 1.80e-03 | 7 | 176 | 2 | SM01062 | |
| Domain | Ca_chan_IQ | 1.80e-03 | 7 | 176 | 2 | PF08763 | |
| Domain | Furin-like | 1.80e-03 | 7 | 176 | 2 | PF00757 | |
| Domain | Rcpt_L-dom | 1.80e-03 | 7 | 176 | 2 | IPR000494 | |
| Domain | Hematopoietin_rcpt_Gp130_CS | 1.80e-03 | 7 | 176 | 2 | IPR003529 | |
| Domain | VDCC_a1su_IQ | 1.80e-03 | 7 | 176 | 2 | IPR014873 | |
| Domain | GPHH | 1.80e-03 | 7 | 176 | 2 | PF16905 | |
| Domain | GPHH_dom | 1.80e-03 | 7 | 176 | 2 | IPR031649 | |
| Domain | Furin-like_Cys-rich_dom | 1.80e-03 | 7 | 176 | 2 | IPR006211 | |
| Domain | - | 1.80e-03 | 7 | 176 | 2 | 3.80.20.20 | |
| Domain | PROTEIN_KINASE_TYR | 2.25e-03 | 97 | 176 | 5 | PS00109 | |
| Domain | Tyr_kinase_AS | 2.25e-03 | 97 | 176 | 5 | IPR008266 | |
| Domain | DHC_N1 | 2.38e-03 | 8 | 176 | 2 | PF08385 | |
| Domain | HEMATOPO_REC_L_F2 | 2.38e-03 | 8 | 176 | 2 | PS01353 | |
| Domain | Dynein_heavy_dom-1 | 2.38e-03 | 8 | 176 | 2 | IPR013594 | |
| Domain | Znf_FYVE_PHD | 2.72e-03 | 147 | 176 | 6 | IPR011011 | |
| Domain | HMG_box_dom | 3.30e-03 | 65 | 176 | 4 | IPR009071 | |
| Domain | Zinc_finger_PHD-type_CS | 3.30e-03 | 65 | 176 | 4 | IPR019786 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TYPE_II_INTERFERON_TO_JAK_STAT_SIGNALING_PATHWAY | 9.90e-12 | 21 | 134 | 8 | M47909 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TYPE_I_IFN_SIGNALING_PATHWAY | 2.35e-11 | 23 | 134 | 8 | M47452 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TYPE_I_INTERFERON_TO_JAK_STAT_SIGNALING_PATHWAY | 3.49e-11 | 24 | 134 | 8 | M47908 | |
| Pathway | REACTOME_REGULATION_OF_IFNA_IFNB_SIGNALING | 7.30e-11 | 26 | 134 | 8 | M982 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_TAT_TO_TLR2_4_NFKB_SIGNALING_PATHWAY | 1.08e-10 | 17 | 134 | 7 | M47564 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CGAS_STING_SIGNALING_PATHWAY | 1.75e-10 | 18 | 134 | 7 | M47539 | |
| Pathway | BIOCARTA_IFNA_PATHWAY | 2.74e-10 | 19 | 134 | 7 | MM1571 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR3_IRF7_SIGNALING_PATHWAY | 2.74e-10 | 19 | 134 | 7 | M47450 | |
| Pathway | WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY | 3.54e-10 | 31 | 134 | 8 | M39897 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IFN_RIPK1_3_SIGNALING_PATHWAY | 3.54e-10 | 31 | 134 | 8 | M47964 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR7_9_IRF7_SIGNALING_PATHWAY | 4.19e-10 | 20 | 134 | 7 | M47617 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR7_8_9_IRF5_SIGNALING_PATHWAY | 9.07e-10 | 22 | 134 | 7 | M47897 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RIG_I_NFKB_SIGNALING_PATHWAY | 9.07e-10 | 22 | 134 | 7 | M47616 | |
| Pathway | REACTOME_EVASION_BY_RSV_OF_HOST_INTERFERON_RESPONSES | 1.02e-09 | 35 | 134 | 8 | M48246 | |
| Pathway | REACTOME_REGULATION_OF_IFNA_IFNB_SIGNALING | 1.29e-09 | 23 | 134 | 7 | MM15634 | |
| Pathway | WP_INTERFERONMEDIATED_SIGNALING | 1.65e-09 | 37 | 134 | 8 | M39785 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MDA5_IRF7_3_SIGNALING_PATHWAY | 1.81e-09 | 24 | 134 | 7 | M47782 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RIG_I_IRF7_3_SIGNALING_PATHWAY | 1.81e-09 | 24 | 134 | 7 | M47576 | |
| Pathway | REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION | 1.02e-08 | 30 | 134 | 7 | M936 | |
| Pathway | REACTOME_INTERFERON_ALPHA_BETA_SIGNALING | 2.60e-08 | 34 | 134 | 7 | MM15631 | |
| Pathway | KEGG_REGULATION_OF_AUTOPHAGY | 3.23e-08 | 35 | 134 | 7 | M6382 | |
| Pathway | KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY | 4.52e-08 | 55 | 134 | 8 | M11844 | |
| Pathway | PID_CD8_TCR_DOWNSTREAM_PATHWAY | 1.73e-07 | 65 | 134 | 8 | M272 | |
| Pathway | BIOCARTA_CYTOKINE_PATHWAY | 2.09e-07 | 28 | 134 | 6 | MM1378 | |
| Pathway | WP_CYTOSOLIC_DNASENSING_PATHWAY | 4.32e-07 | 73 | 134 | 8 | M39837 | |
| Pathway | KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY | 5.25e-07 | 102 | 134 | 9 | M3261 | |
| Pathway | KEGG_AUTOIMMUNE_THYROID_DISEASE | 5.61e-07 | 52 | 134 | 7 | M13103 | |
| Pathway | WP_TOLLLIKE_RECEPTOR_SIGNALING | 5.71e-07 | 103 | 134 | 9 | M39434 | |
| Pathway | BIOCARTA_INFLAM_PATHWAY | 5.91e-07 | 33 | 134 | 6 | MM1379 | |
| Pathway | REACTOME_INTERFERON_ALPHA_BETA_SIGNALING | 7.24e-07 | 78 | 134 | 8 | M973 | |
| Pathway | WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE | 1.66e-06 | 39 | 134 | 6 | MM15914 | |
| Pathway | WP_IL2_SIGNALING_PATHWAY | 1.68e-06 | 87 | 134 | 8 | MM15915 | |
| Pathway | REACTOME_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_PATHWAY | 2.08e-06 | 120 | 134 | 9 | M48233 | |
| Pathway | KEGG_JAK_STAT_SIGNALING_PATHWAY | IL12RB2 IFNA4 IFNA5 IFNA6 IFNA7 IFNA14 IFNA17 IFNA21 JAK1 LIFR | 2.19e-06 | 155 | 134 | 10 | M17411 |
| Pathway | BIOCARTA_IL1R_PATHWAY | 2.26e-06 | 41 | 134 | 6 | MM1493 | |
| Pathway | WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS | 3.33e-06 | 127 | 134 | 9 | M42533 | |
| Pathway | REACTOME_RSV_HOST_INTERACTIONS | 4.15e-06 | 98 | 134 | 8 | M48247 | |
| Pathway | KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY | 4.80e-06 | 71 | 134 | 7 | M15913 | |
| Pathway | KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY | 6.21e-06 | 137 | 134 | 9 | M5669 | |
| Pathway | KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION | IL12RB2 FLT4 IFNA4 IFNA5 IFNA6 IFNA7 IFNA14 IFNA17 IFNA21 LIFR CCL3 CCL5 | 8.06e-06 | 264 | 134 | 12 | M9809 |
| Pathway | REACTOME_DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA | 1.26e-05 | 82 | 134 | 7 | M1002 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | HSP90B1 FLT4 INSR CHRM1 IFNA4 IFNA5 IFNA6 IFNA7 IFNA14 IFNA17 IFNA21 JAK1 IGF1R | 1.37e-05 | 326 | 134 | 13 | MM15917 |
| Pathway | WP_HEPATITIS_B_INFECTION | 1.37e-05 | 151 | 134 | 9 | M39801 | |
| Pathway | KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION | 2.01e-05 | 88 | 134 | 7 | M16004 | |
| Pathway | WP_PI3KAKT_SIGNALING | HSP90B1 FLT4 INSR CHRM1 IFNA4 IFNA5 IFNA6 IFNA7 IFNA14 IFNA17 IFNA21 JAK1 IGF1R | 2.06e-05 | 339 | 134 | 13 | M39736 |
| Pathway | WP_CANCER_PATHWAYS | IL12RB2 HSP90B1 FLT4 ETS1 ARHGEF12 IFNA4 IFNA5 IFNA6 IFNA7 IFNA14 IFNA17 IFNA21 JAK1 IGF1R PRKCB FH | 2.51e-05 | 507 | 134 | 16 | M48302 |
| Pathway | REACTOME_SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES | 2.65e-05 | 126 | 134 | 8 | M45009 | |
| Pathway | REACTOME_ABACAVIR_ADME | 4.54e-05 | 8 | 134 | 3 | MM14869 | |
| Pathway | WP_MEASLES_VIRUS_INFECTION | 4.59e-05 | 136 | 134 | 8 | M42547 | |
| Pathway | WP_FATTY_ACID_OMEGAOXIDATION | 9.60e-05 | 10 | 134 | 3 | MM15833 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 1.31e-04 | 11 | 134 | 3 | M47958 | |
| Pathway | REACTOME_ETHANOL_OXIDATION | 1.31e-04 | 11 | 134 | 3 | MM15405 | |
| Pathway | REACTOME_HDMS_DEMETHYLATE_HISTONES | 1.54e-04 | 29 | 134 | 4 | MM14934 | |
| Pathway | REACTOME_ETHANOL_OXIDATION | 1.74e-04 | 12 | 134 | 3 | M14663 | |
| Pathway | REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION | 2.18e-04 | 170 | 134 | 8 | M941 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_US28_TO_GNA12_13_RHO_SIGNALING_PATHWAY | 2.24e-04 | 13 | 134 | 3 | M47547 | |
| Pathway | REACTOME_INTERFERON_SIGNALING | TRIM34 IFNA4 IFNA5 IFNA6 IFNA7 IFNA14 IFNA17 IFNA21 JAK1 GBP4 | 2.79e-04 | 273 | 134 | 10 | M983 |
| Pathway | REACTOME_INTERFERON_SIGNALING | 3.46e-04 | 138 | 134 | 7 | MM15635 | |
| Pathway | WP_FATTY_ACID_OMEGAOXIDATION | 3.51e-04 | 15 | 134 | 3 | M39717 | |
| Pathway | KEGG_TYROSINE_METABOLISM | 6.60e-04 | 42 | 134 | 4 | M16743 | |
| Pathway | REACTOME_SCAVENGING_BY_CLASS_A_RECEPTORS | 7.28e-04 | 19 | 134 | 3 | M27221 | |
| Pathway | REACTOME_SARS_COV_2_HOST_INTERACTIONS | 7.36e-04 | 204 | 134 | 8 | M45011 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KERATAN_SULFATE_DEGRADATION | 8.80e-04 | 5 | 134 | 2 | M47609 | |
| Pathway | REACTOME_HDMS_DEMETHYLATE_HISTONES | 1.28e-03 | 50 | 134 | 4 | M27232 | |
| Pathway | REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM | IL12RB2 HSP90B1 PELI2 PELI1 TRIM34 IFNA4 IFNA5 IFNA6 IFNA7 IFNA14 IFNA17 IFNA21 JAK1 LIFR GBP4 CCL3 CCL5 | 1.30e-03 | 789 | 134 | 17 | M1060 |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_VGCC_CA2_APOPTOTIC_PATHWAY | 1.31e-03 | 6 | 134 | 2 | M47762 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 1.41e-03 | 175 | 134 | 7 | MM14941 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_ENTRY_VOLTAGE_GATED_CA2_CHANNEL | 1.66e-03 | 25 | 134 | 3 | M47948 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_UBIQUITINATION_OF_RTK_BY_CBL | 1.66e-03 | 25 | 134 | 3 | M47934 | |
| Pathway | REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM | IL12RB2 HSP90B1 PELI2 PELI1 IFNA4 IFNA5 IFNA6 IFNA7 IFNA14 IFNA17 IFNA21 LIFR | 1.81e-03 | 472 | 134 | 12 | MM14539 |
| Pathway | WP_INTERACTIONS_OF_NATURAL_KILLER_CELLS_IN_PANCREATIC_CANCER | 2.31e-03 | 28 | 134 | 3 | M42549 | |
| Pathway | REACTOME_RA_BIOSYNTHESIS_PATHWAY | 2.31e-03 | 28 | 134 | 3 | MM15188 | |
| Pubmed | 6.62e-16 | 13 | 184 | 8 | 7510216 | ||
| Pubmed | 3.28e-15 | 15 | 184 | 8 | 9520456 | ||
| Pubmed | 1.69e-14 | 28 | 184 | 9 | 15481145 | ||
| Pubmed | TYK2 and JAK2 are substrates of protein-tyrosine phosphatase 1B. | 6.28e-14 | 20 | 184 | 8 | 11694501 | |
| Pubmed | 8.01e-14 | 12 | 184 | 7 | 16565497 | ||
| Pubmed | Evolution of the interferon alpha gene family in eutherian mammals. | 8.01e-14 | 12 | 184 | 7 | 17512142 | |
| Pubmed | Repression of the murine interferon alpha 11 gene: identification of negatively acting sequences. | 8.01e-14 | 12 | 184 | 7 | 1886773 | |
| Pubmed | Multiple pathways of interferon-induced gene expression in murine macrophages. | 8.01e-14 | 12 | 184 | 7 | 7684767 | |
| Pubmed | Negative regulation of the alpha interferon-induced antiviral response by the Ras/Raf/MEK pathway. | 8.01e-14 | 12 | 184 | 7 | 16611902 | |
| Pubmed | Interferon-alpha subtype 11 activates NK cells and enables control of retroviral infection. | 8.01e-14 | 12 | 184 | 7 | 22912583 | |
| Pubmed | Structure and expression of a new murine interferon-alpha gene: MuIFN-alpha I9. | 8.01e-14 | 12 | 184 | 7 | 3758677 | |
| Pubmed | 8.01e-14 | 12 | 184 | 7 | 8245849 | ||
| Pubmed | 8.01e-14 | 12 | 184 | 7 | 11846978 | ||
| Pubmed | Identification of distal silencing elements in the murine interferon-A11 gene promoter. | 8.01e-14 | 12 | 184 | 7 | 8760352 | |
| Pubmed | Role of interferons in the regulation of cell proliferation, differentiation, and development. | 8.01e-14 | 12 | 184 | 7 | 7530016 | |
| Pubmed | 8.01e-14 | 12 | 184 | 7 | 9794206 | ||
| Pubmed | 8.01e-14 | 12 | 184 | 7 | 17451966 | ||
| Pubmed | 1.58e-13 | 22 | 184 | 8 | 16160188 | ||
| Pubmed | Characterization of interferon-alpha 13, a novel constitutive murine interferon-alpha subtype. | 1.73e-13 | 13 | 184 | 7 | 12930842 | |
| Pubmed | Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release. | 1.73e-13 | 13 | 184 | 7 | 2014240 | |
| Pubmed | 1.73e-13 | 13 | 184 | 7 | 18005734 | ||
| Pubmed | 1.73e-13 | 13 | 184 | 7 | 12050368 | ||
| Pubmed | Isolation and bacterial expression of a murine alpha leukocyte interferon gene. | 1.73e-13 | 13 | 184 | 7 | 6094686 | |
| Pubmed | 1.73e-13 | 13 | 184 | 7 | 1655578 | ||
| Pubmed | 1.73e-13 | 13 | 184 | 7 | 2471809 | ||
| Pubmed | 1.73e-13 | 13 | 184 | 7 | 8438572 | ||
| Pubmed | 1.73e-13 | 13 | 184 | 7 | 9343822 | ||
| Pubmed | Evidence for a different susceptibility of primate lentiviruses to type I interferons. | 1.73e-13 | 13 | 184 | 7 | 23255800 | |
| Pubmed | 1.73e-13 | 13 | 184 | 7 | 7523540 | ||
| Pubmed | 1.73e-13 | 13 | 184 | 7 | 19706714 | ||
| Pubmed | Organization, structure and expression of murine interferon alpha genes. | 1.73e-13 | 13 | 184 | 7 | 2987810 | |
| Pubmed | 1.73e-13 | 13 | 184 | 7 | 19130550 | ||
| Pubmed | 1.73e-13 | 13 | 184 | 7 | 22739040 | ||
| Pubmed | 1.73e-13 | 13 | 184 | 7 | 9181467 | ||
| Pubmed | Sequencing and bacterial expression of a novel murine alpha interferon gene. | 1.73e-13 | 13 | 184 | 7 | 18726328 | |
| Pubmed | 1.73e-13 | 13 | 184 | 7 | 18572754 | ||
| Pubmed | 3.44e-13 | 14 | 184 | 7 | 22815848 | ||
| Pubmed | Alpha interferon suppresses the cyclin D3 and cdc25A genes, leading to a reversible G0-like arrest. | 3.44e-13 | 14 | 184 | 7 | 8668211 | |
| Pubmed | Interferon induction by HIV glycoprotein 120: role of the V3 loop. | 3.44e-13 | 14 | 184 | 7 | 7526537 | |
| Pubmed | 3.44e-13 | 14 | 184 | 7 | 19559726 | ||
| Pubmed | 3.44e-13 | 14 | 184 | 7 | 15240719 | ||
| Pubmed | 3.44e-13 | 14 | 184 | 7 | 16418394 | ||
| Pubmed | 3.44e-13 | 14 | 184 | 7 | 18272764 | ||
| Pubmed | 3.44e-13 | 14 | 184 | 7 | 11884139 | ||
| Pubmed | 3.44e-13 | 14 | 184 | 7 | 19004943 | ||
| Pubmed | 3.44e-13 | 14 | 184 | 7 | 2552026 | ||
| Pubmed | Modulation of interferon-mediated inhibition of human immunodeficiency virus type 1 by Tat. | 3.44e-13 | 14 | 184 | 7 | 7532202 | |
| Pubmed | 3.44e-13 | 14 | 184 | 7 | 18200012 | ||
| Pubmed | Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. | 3.44e-13 | 14 | 184 | 7 | 18200009 | |
| Pubmed | A structural basis for interferon-alpha-receptor interactions. | 3.44e-13 | 14 | 184 | 7 | 17517919 | |
| Pubmed | 3.44e-13 | 14 | 184 | 7 | 14983024 | ||
| Pubmed | 3.44e-13 | 14 | 184 | 7 | 25972534 | ||
| Pubmed | 3.44e-13 | 14 | 184 | 7 | 7583919 | ||
| Pubmed | 3.44e-13 | 14 | 184 | 7 | 2987811 | ||
| Pubmed | 3.44e-13 | 14 | 184 | 7 | 21172865 | ||
| Pubmed | Characterization of the murine alpha interferon gene family. | 3.44e-13 | 14 | 184 | 7 | 15254193 | |
| Pubmed | 3.44e-13 | 14 | 184 | 7 | 16278001 | ||
| Pubmed | Recombinant glycoprotein 120 of human immunodeficiency virus is a potent interferon inducer. | 3.44e-13 | 14 | 184 | 7 | 1381203 | |
| Pubmed | 3.44e-13 | 14 | 184 | 7 | 8345204 | ||
| Pubmed | 5.27e-13 | 25 | 184 | 8 | 27183626 | ||
| Pubmed | 6.42e-13 | 15 | 184 | 7 | 8786318 | ||
| Pubmed | 6.42e-13 | 15 | 184 | 7 | 15684736 | ||
| Pubmed | Are CD4 and Fas peptide identities of gp120 relevant to the molecular basis of AIDS pathogenesis? | 6.42e-13 | 15 | 184 | 7 | 17180012 | |
| Pubmed | Role of the Akt pathway in mRNA translation of interferon-stimulated genes. | 6.42e-13 | 15 | 184 | 7 | 18339807 | |
| Pubmed | Interferon induction by HIV-1-infected cells: a possible role of sulfatides or related glycolipids. | 6.42e-13 | 15 | 184 | 7 | 8661419 | |
| Pubmed | 7.58e-13 | 26 | 184 | 8 | 9658081 | ||
| Pubmed | Decoding type I and III interferon signalling during viral infection. | 1.07e-12 | 27 | 184 | 8 | 30936491 | |
| Pubmed | Role of retroviral restriction factors in the interferon-α-mediated suppression of HIV-1 in vivo. | 1.14e-12 | 16 | 184 | 7 | 22315404 | |
| Pubmed | Coordinate induction of interferon alpha and gamma by recombinant HIV-1 glycoprotein 120. | 1.14e-12 | 16 | 184 | 7 | 7904170 | |
| Pubmed | Sialoadhesin expressed on IFN-induced monocytes binds HIV-1 and enhances infectivity. | 1.14e-12 | 16 | 184 | 7 | 18414664 | |
| Pubmed | 1.35e-12 | 63 | 184 | 10 | 12089333 | ||
| Pubmed | 1.92e-12 | 17 | 184 | 7 | 22814248 | ||
| Pubmed | Characterization of the type I interferon locus and identification of novel genes. | 1.92e-12 | 17 | 184 | 7 | 15233997 | |
| Pubmed | 3.13e-12 | 18 | 184 | 7 | 1905933 | ||
| Pubmed | 4.94e-12 | 19 | 184 | 7 | 7511078 | ||
| Pubmed | 4.94e-12 | 19 | 184 | 7 | 7815507 | ||
| Pubmed | 4.94e-12 | 19 | 184 | 7 | 17360657 | ||
| Pubmed | Translational regulation by HIV leader RNA, TAT, and interferon-inducible enzymes. | 4.94e-12 | 19 | 184 | 7 | 1708818 | |
| Pubmed | 4.94e-12 | 19 | 184 | 7 | 1385305 | ||
| Pubmed | 7.57e-12 | 20 | 184 | 7 | 8764000 | ||
| Pubmed | 9.13e-12 | 11 | 184 | 6 | 18835032 | ||
| Pubmed | High-affinity binding of 125I-labelled mouse interferon to a specific cell surface receptor. | 9.13e-12 | 11 | 184 | 6 | 6444699 | |
| Pubmed | Structural and functional neuropathology in transgenic mice with CNS expression of IFN-alpha. | 9.13e-12 | 11 | 184 | 6 | 10448195 | |
| Pubmed | IFN-alpha can both protect against and promote the development of type 1 diabetes. | 9.13e-12 | 11 | 184 | 6 | 19120292 | |
| Pubmed | Effect of interferon-alpha on immediate early gene expression of murine cytomegalovirus. | 9.13e-12 | 11 | 184 | 6 | 8389790 | |
| Pubmed | The mouse IFN-alpha (Ifa) locus: correlation of physical and linkage maps by in situ hybridization. | 9.13e-12 | 11 | 184 | 6 | 3456887 | |
| Pubmed | Mechanism of SUMOylation-Mediated Regulation of Type I IFN Expression. | 9.13e-12 | 11 | 184 | 6 | 36681180 | |
| Pubmed | Type I interferon dependence of plasmacytoid dendritic cell activation and migration. | 9.13e-12 | 11 | 184 | 6 | 15795237 | |
| Pubmed | 9.13e-12 | 11 | 184 | 6 | 9794439 | ||
| Pubmed | 9.13e-12 | 11 | 184 | 6 | 25310498 | ||
| Pubmed | 1.13e-11 | 21 | 184 | 7 | 9108403 | ||
| Pubmed | 1.65e-11 | 22 | 184 | 7 | 7913356 | ||
| Pubmed | 1.65e-11 | 22 | 184 | 7 | 23100517 | ||
| Pubmed | Regulation of effector and memory T-cell functions by type I interferon. | 1.82e-11 | 12 | 184 | 6 | 21320124 | |
| Pubmed | MAVS Deficiency Is Associated With a Reduced T Cell Response Upon Secondary RSV Infection in Mice. | 1.82e-11 | 12 | 184 | 6 | 33123150 | |
| Pubmed | A novel anti-viral role for STAT3 in IFN-α signalling responses. | 1.82e-11 | 12 | 184 | 6 | 27988795 | |
| Pubmed | 1.82e-11 | 12 | 184 | 6 | 9425112 | ||
| Pubmed | 1.82e-11 | 12 | 184 | 6 | 8656058 | ||
| Pubmed | The physical separation of Lps and Ifa loci in BXH recombinant inbred mice. | 1.82e-11 | 12 | 184 | 6 | 2572648 | |
| Pubmed | Developmental control of IFN-alpha expression in murine embryos. | 1.82e-11 | 12 | 184 | 6 | 7925651 | |
| Interaction | IFNA1 interactions | 2.35e-07 | 16 | 183 | 5 | int:IFNA1 | |
| Interaction | IFNA6 interactions | 4.48e-07 | 8 | 183 | 4 | int:IFNA6 | |
| Interaction | IFNA5 interactions | 1.36e-06 | 22 | 183 | 5 | int:IFNA5 | |
| Interaction | IFNA14 interactions | 1.10e-05 | 16 | 183 | 4 | int:IFNA14 | |
| Cytoband | 9p22 | 6.96e-12 | 25 | 185 | 7 | 9p22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9p21 | 4.41e-08 | 124 | 185 | 8 | chr9p21 | |
| Cytoband | 4q23 | 6.98e-05 | 20 | 185 | 3 | 4q23 | |
| Cytoband | Xp21.1 | 3.51e-04 | 34 | 185 | 3 | Xp21.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q23 | 4.52e-04 | 37 | 185 | 3 | chr4q23 | |
| GeneFamily | Interferons | 2.08e-09 | 32 | 127 | 7 | 598 | |
| GeneFamily | Alcohol dehydrogenases | 1.85e-05 | 8 | 127 | 3 | 397 | |
| GeneFamily | PHD finger proteins|Lysine demethylases | 2.21e-05 | 24 | 127 | 4 | 485 | |
| GeneFamily | Pellino E3 ubiquitin protein ligases | 1.46e-04 | 3 | 127 | 2 | 676 | |
| GeneFamily | Dyneins, axonemal | 2.14e-04 | 17 | 127 | 3 | 536 | |
| GeneFamily | Calcium voltage-gated channel subunits | 7.82e-04 | 26 | 127 | 3 | 253 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 2.77e-03 | 40 | 127 | 3 | 321 | |
| GeneFamily | Kelch like|BTB domain containing | 3.18e-03 | 42 | 127 | 3 | 617 | |
| GeneFamily | PHD finger proteins | 3.72e-03 | 90 | 127 | 4 | 88 | |
| GeneFamily | Ring finger proteins|Tripartite motif containing|ARF GTPase family | 4.52e-03 | 95 | 127 | 4 | 59 | |
| Coexpression | ERWIN_COHEN_PBMC_TC_83_AGE_18_45YO_NAIVE_NOT_PREVIOUSLY_IMMUNIZED_24HR_DEG_CANONICAL_PATHWAY_MEMBERS_UP | 9.18e-09 | 39 | 183 | 7 | M41095 | |
| Coexpression | SHIN_B_CELL_LYMPHOMA_CLUSTER_5 | 4.43e-08 | 29 | 183 | 6 | MM586 | |
| Coexpression | CUI_DEVELOPING_HEART_TRABECULAR_ATRIAL_CARDIOMYOCYTE | 5.60e-07 | 179 | 183 | 10 | M39308 | |
| Coexpression | WORSCHECH_TUMOR_REJECTION_UP | 1.49e-06 | 80 | 183 | 7 | MM1229 | |
| Coexpression | LEE_CALORIE_RESTRICTION_NEOCORTEX_DN | 2.25e-06 | 85 | 183 | 7 | MM684 | |
| Coexpression | LEE_CALORIE_RESTRICTION_NEOCORTEX_UP | 2.63e-06 | 87 | 183 | 7 | MM652 | |
| Coexpression | GROSS_HYPOXIA_VIA_HIF1A_DN | 4.03e-06 | 131 | 183 | 8 | MM1127 | |
| Coexpression | ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_DN | 6.54e-06 | 38 | 183 | 5 | M1751 | |
| Coexpression | SCHLOSSER_SERUM_RESPONSE_DN | HEXB UBR2 EED BCLAF1 INSR CIR1 MTMR1 NECTIN3 CDC40 UPF2 KLHL23 KDM4A DLEC1 RP2 PCMT1 ARAP2 DOP1B | 9.95e-06 | 705 | 183 | 17 | M1410 |
| Coexpression | ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_DN | 1.08e-05 | 42 | 183 | 5 | MM733 | |
| Coexpression | GSE2405_0H_VS_3H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN | CACNA2D1 HSP90B1 DOCK10 CBFA2T3 DNAH14 ADH1B CHD5 ENPP5 DNAH9 | 1.12e-05 | 198 | 183 | 9 | M6213 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPROGM | ARHGEF28 MAP6 FAT3 PPIL6 APOA1 NECTIN3 TRIM59 MLF1 MAD2L1 CAP2 ARAP2 | 1.14e-05 | 307 | 183 | 11 | M39058 |
| Coexpression | GSE8515_CTRL_VS_IL1_4H_STIM_MAC_UP | 1.17e-05 | 199 | 183 | 9 | M5759 | |
| Coexpression | GSE14350_IL2RB_KO_VS_WT_TEFF_DN | 1.21e-05 | 200 | 183 | 9 | M3424 | |
| Coexpression | GSE7852_LN_VS_THYMUS_TREG_UP | 1.21e-05 | 200 | 183 | 9 | M5737 | |
| Coexpression | IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP | 1.79e-05 | 210 | 183 | 9 | MM751 | |
| Coexpression | LEE_AGING_NEOCORTEX_DN | 2.09e-05 | 80 | 183 | 6 | MM646 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | UBR2 NRIP1 USP13 VRK1 HIVEP2 NECTIN3 PHF8 ZZEF1 DCUN1D4 TRIP12 KLHL20 IGF1R UPF2 STK24 CAP2 PCMT1 ARAP2 DOP1B | 3.35e-05 | 856 | 183 | 18 | M4500 |
| Coexpression | PUJANA_ATM_PCC_NETWORK | HEXA UBR2 VRK1 EED MYO1A PPIL6 ETS1 DOCK10 CIR1 MTMR1 GRIA1 CBFA2T3 RRM1 CHRND GTF2H4 UPF2 CTR9 KLHL23 CCL3 DNAJC24 KDM4A BRD1 DNA2 MAD2L1 | 4.17e-05 | 1394 | 183 | 24 | M9585 |
| Coexpression | VEGF_A_UP.V1_DN | 6.66e-05 | 193 | 183 | 8 | M2675 | |
| Coexpression | YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN | CACNA1B PRAMEF33 PRAMEF10 BCLAF1 GRIA1 NECTIN3 NEB FOCAD PYGM EPHA1 | 6.73e-05 | 309 | 183 | 10 | MM1244 |
| Coexpression | GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_RAG2_KO_NK_CELL_UP | 7.16e-05 | 195 | 183 | 8 | M8872 | |
| Coexpression | GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_18H_UP | 7.97e-05 | 198 | 183 | 8 | M4283 | |
| Coexpression | GSE22886_NAIVE_TCELL_VS_NKCELL_DN | 7.97e-05 | 198 | 183 | 8 | M4415 | |
| Coexpression | GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_6H_DN | 8.25e-05 | 199 | 183 | 8 | M6172 | |
| Coexpression | GSE17721_POLYIC_VS_CPG_1H_BMDC_DN | 8.54e-05 | 200 | 183 | 8 | M3936 | |
| Coexpression | GSE37301_MULTIPOTENT_PROGENITOR_VS_RAG2_KO_NK_CELL_UP | 8.54e-05 | 200 | 183 | 8 | M8850 | |
| Coexpression | GSE24492_LYVE_NEG_VS_POS_MACROPHAGE_DN | 8.54e-05 | 200 | 183 | 8 | M7873 | |
| Coexpression | ERWIN_COHEN_PBMC_TC_83_AGE_18_45YO_RESPONDERS_PREVIOUSLY_IMMUNIZED_24HR_DEG_CANONICAL_PATHWAY_MEMBERS_UP | 9.05e-05 | 34 | 183 | 4 | M41094 | |
| Coexpression | PUJANA_CHEK2_PCC_NETWORK | USP13 VRK1 EED MYO1A RRM1 RRM2 GTF2H4 CTR9 KLHL23 DNAJC24 KDM4A MPHOSPH6 DNA2 STK24 MAD2L1 PCMT1 | 9.33e-05 | 761 | 183 | 16 | M11961 |
| Coexpression | STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP | 1.05e-04 | 206 | 183 | 8 | M2817 | |
| Coexpression | STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP | 1.12e-04 | 208 | 183 | 8 | MM581 | |
| Coexpression | VERNELL_RETINOBLASTOMA_PATHWAY_UP | 1.23e-04 | 69 | 183 | 5 | M15969 | |
| Coexpression | NABA_SECRETED_FACTORS | 1.41e-04 | 338 | 183 | 10 | MM17064 | |
| Coexpression | JOHNSTONE_PARVB_TARGETS_3_DN | EED OXR1 ARHGEF12 RRM1 RRM2 KLHL20 PCNX4 KLHL23 MIB1 MLF1 DNAJC24 RP2 MPHOSPH6 FH POMK MAD2L1 PCMT1 | 1.49e-04 | 877 | 183 | 17 | M2241 |
| Coexpression | NABA_SECRETED_FACTORS | 1.58e-04 | 343 | 183 | 10 | M5883 | |
| Coexpression | BROWNE_HCMV_INFECTION_16HR_UP | 1.81e-04 | 223 | 183 | 8 | M11383 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_top-relative-expression-ranked_1000 | CACNA1B CACNA2D1 ABCC4 HIVEP2 DRAM1 DSP INSR PPIL6 MTMR1 PELI1 NEB BDH1 RYR3 ADH1C KCNQ5 GBP4 LMO7 MIB1 PRKCB SNTG2 CAP2 ARAP2 | 4.21e-07 | 772 | 175 | 22 | gudmap_developingLowerUrinaryTract_P1_bladder_1000_J |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#2_top-relative-expression-ranked_500 | 2.56e-06 | 105 | 175 | 8 | gudmap_developingLowerUrinaryTract_P1_bladder_J_500_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_k-means-cluster#2_top-relative-expression-ranked_1000 | CACNA1C CACNA2D1 DRAM1 PPIL6 MTMR1 BDH1 RYR3 KCNQ5 KLHL23 PRKCB SNTG2 CAP2 | 2.44e-05 | 337 | 175 | 12 | gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_1000_k2 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_bladder_emap-29457_k-means-cluster#1_top-relative-expression-ranked_1000 | 3.21e-05 | 148 | 175 | 8 | gudmap_developingLowerUrinaryTract_adult_bladder_1000_k1 | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_k-means-cluster#2_top-relative-expression-ranked_1000 | 6.36e-05 | 163 | 175 | 8 | gudmap_kidney_P0_JuxtaGlom_Ren1_k2_1000 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2+.Sp, TCRd+ Vg2+ CD44-, Spleen, avg-3 | NRIP1 HIVEP2 ETS1 PELI1 BDH1 TRIM59 JAK1 ESYT2 CCL5 XKRX FKBP3 ARAP2 | 9.02e-05 | 386 | 175 | 12 | GSM605787_500 |
| CoexpressionAtlas | alpha beta T cells, T.4.Pa.BDC, 4+ 8- BDC+, Pancreas, avg-2 | NRIP1 HIVEP2 ETS1 PELI1 BDH1 TRIM59 ADH1C JAK1 ESYT2 XKRX ARAP2 | 9.14e-05 | 328 | 175 | 11 | GSM605756_500 |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#4_top-relative-expression-ranked_500 | 9.28e-05 | 172 | 175 | 8 | gudmap_developingGonad_e11.5_ovary + mesonephros_k4_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | CACNA1B NRIP1 CACNA2D1 ABCC4 MAP6 DSP FAT3 INSR GRIA1 PELI1 RRM1 RYR3 JAK1 LIFR SLC12A2 KCNQ5 MIB1 KIF13A | 1.50e-04 | 818 | 175 | 18 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 |
| CoexpressionAtlas | kidney_adult_Mesangium_Meis_k-means-cluster#2_top-relative-expression-ranked_1000 | CACNA2D1 ETS1 DOCK10 ESYT2 SLC12A2 KCNQ5 LMO7 FAM161A PYGM DCBLD2 ARAP2 | 1.54e-04 | 348 | 175 | 11 | gudmap_kidney_adult_Mesangium_Meis_k2_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_k-means-cluster#4_top-relative-expression-ranked_100 | 1.70e-04 | 34 | 175 | 4 | gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_100_k4 | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_top-relative-expression-ranked_1000 | CACNA1C CACNA2D1 HIVEP2 FAT3 INSR PPIL6 CPE ADH1C RHOQ ESYT2 SLC12A2 LMO7 ENPP5 PYGM PLD5 PLS3 CAP2 ARAP2 ADSS1 | 1.78e-04 | 905 | 175 | 19 | gudmap_kidney_P0_JuxtaGlom_Ren1_1000 |
| CoexpressionAtlas | kidney_adult_RenCorpuscGlomer_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.31e-04 | 148 | 175 | 7 | gudmap_kidney_adult_RenCorpuscGlomer_k4_1000 | |
| CoexpressionAtlas | kidney_adult_Mesangium_Meis_top-relative-expression-ranked_500 | CACNA2D1 HIVEP2 ETS1 DOCK10 LIFR SLC12A2 GBP4 LMO7 PYGM DCBLD2 PLS3 ARAP2 | 2.40e-04 | 429 | 175 | 12 | gudmap_kidney_adult_Mesangium_Meis_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#1_top-relative-expression-ranked_1000 | 2.41e-04 | 149 | 175 | 7 | gudmap_developingLowerUrinaryTract_P1_bladder_J_1000_k1 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | DHX36 NRIP1 DCAF6 PELI1 PIWIL2 NHLRC2 SPA17 NEB TEF TRIM66 TH ZC3H11A SLC12A2 MIB1 RP2 GREB1 GABRA4 | 2.50e-04 | 778 | 175 | 17 | gudmap_developingGonad_e18.5_ovary_1000 |
| CoexpressionAtlas | NK cells, NK.49CI-.Sp, NK1.1+ CD3- Ly49C/I-, Spleen, avg-3 | IL12RB2 OXR1 JAK1 RHOQ ESYT2 KCNQ5 ENPP5 CCL3 CCL5 ARAP2 MCOLN2 | 2.73e-04 | 372 | 175 | 11 | GSM538288_500 |
| CoexpressionAtlas | kidney_adult_Mesangium_Meis_top-relative-expression-ranked_1000 | CACNA2D1 HIVEP2 ETS1 DOCK10 ARHGEF12 TRIM34 LIFR ESYT2 SLC12A2 KCNQ5 GBP4 LMO7 FAM161A ENPP5 PYGM DCBLD2 PLS3 ARAP2 | 3.26e-04 | 872 | 175 | 18 | gudmap_kidney_adult_Mesangium_Meis_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_k-means-cluster#2_top-relative-expression-ranked_500 | 3.31e-04 | 157 | 175 | 7 | gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_500_k2 | |
| CoexpressionAtlas | Myeloid Cells, DC.4+.Sp, CD11b CD45 CD4 CD11c CD8a, Spleen, avg-1 | IL12RB2 DPY19L1 DOCK10 CBFA2T3 SLC12A2 PRKCB CCL3 CCL5 RP2 DNA2 ARAP2 | 3.42e-04 | 382 | 175 | 11 | GSM538248_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_500 | 3.56e-04 | 41 | 175 | 4 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000 | CACNA1B CACNA2D1 ABCC4 DSP FAT3 INSR PELI1 TRIP12 RYR3 LIFR SLC12A2 CTR9 MIB1 SNTG2 DCBLD2 CAP2 ARAP2 | 3.75e-04 | 806 | 175 | 17 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_top-relative-expression-ranked_500 | CACNA2D1 DSP INSR PPIL6 NEB BDH1 RYR3 ADH1C KCNQ5 PRKCB SNTG2 | 3.90e-04 | 388 | 175 | 11 | gudmap_developingLowerUrinaryTract_P1_bladder_500_J |
| CoexpressionAtlas | NK cells, NK.b2m-.Sp, NK1.1+ TCRb-, Spleen, avg-3 | IL12RB2 OXR1 JAK1 RHOQ ESYT2 KCNQ5 ENPP5 CCL3 CCL5 ARAP2 MCOLN2 | 4.07e-04 | 390 | 175 | 11 | GSM538291_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_top-relative-expression-ranked_200 | 4.30e-04 | 164 | 175 | 7 | gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_200 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | CACNA1B CACNA1C HIVEP2 OXR1 GRIA1 FOCAD KCNQ5 CHD5 PRKCB DPY19L2P1 CAP2 | 7.49e-10 | 198 | 185 | 11 | c01091ef18e096d792ea2a7a715764a5b215355f |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | CACNA1B CACNA1C OXR1 GRIA1 FOCAD KCNQ5 CHD5 PRKCB DPY19L2P1 CAP2 GABRA4 | 7.49e-10 | 198 | 185 | 11 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | CACNA1B CACNA1C HIVEP2 OXR1 FOCAD KCNQ5 CHD5 PRKCB UNC13A DPY19L2P1 CAP2 | 7.49e-10 | 198 | 185 | 11 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | CACNA1C CACNA2D1 HIVEP2 FAT3 FOCAD KCNQ5 PRKCB UNC13A DPY19L2P1 CAP2 | 9.72e-09 | 195 | 185 | 10 | 2e1df01bf6e4e98e6cd9fb50926e34c5077b8666 |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | CACNA1B CACNA1C OXR1 GRIA1 FOCAD KCNQ5 CHD5 PRKCB DPY19L2P1 CAP2 | 1.02e-08 | 196 | 185 | 10 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | CACNA1B CACNA1C OXR1 GRIA1 FOCAD KCNQ5 CHD5 DPY19L2P1 CAP2 GABRA4 | 1.12e-08 | 198 | 185 | 10 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | CACNA1B CACNA1C OXR1 GRIA1 FOCAD KCNQ5 CHD5 PRKCB DPY19L2P1 CAP2 | 1.24e-08 | 200 | 185 | 10 | 48d801219bc771d6c7e151dc88ca4c179988de85 |
| ToppCell | Adult-Immune-natural_killer_cell-D231|Adult / Lineage, Cell type, age group and donor | 7.41e-08 | 182 | 185 | 9 | dbf47bf4754d8ec3bc3ab1d5be7a6c47a7afbf43 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 9.78e-08 | 188 | 185 | 9 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | Hippocampus-Neuronal-Excitatory|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.02e-07 | 189 | 185 | 9 | 4b90d181eb0a42814eeb23bc82e52fd3a12392a7 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | CACNA2D1 DCAF6 FAT3 NECTIN3 FOCAD KCNQ5 PRKCB DPY19L2P1 ARAP2 | 1.02e-07 | 189 | 185 | 9 | c3df0e3c50af8f1cfb4d790e668bd7f42b276992 |
| ToppCell | COVID-19-lung-NK/NKT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.22e-07 | 193 | 185 | 9 | c24b44fcc92fff42ebba6f1aff91c7aaea179e56 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 1.66e-07 | 200 | 185 | 9 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.57e-07 | 169 | 185 | 8 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_NKT-iNKT/MAIT-iNKT-MAIT|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.25e-07 | 178 | 185 | 8 | f914092c20130207193f97c6044ae61a9a440a86 | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_NKT-iNKT/MAIT|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.25e-07 | 178 | 185 | 8 | 7905621f5b2aa55324c5592d1d2fef763a5fa41f | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.15e-06 | 186 | 185 | 8 | 84ba666237c18189d7e7556bd92dd953af733c00 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.20e-06 | 187 | 185 | 8 | f18628ffc7ff7c762b8339ba8822cf0c3157f469 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 1.29e-06 | 189 | 185 | 8 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | COVID-19-T_cells-NK_cells|COVID-19 / group, cell type (main and fine annotations) | 1.29e-06 | 189 | 185 | 8 | b699152dfbb8cd8ed724e1e5a51838f29b681b62 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.35e-06 | 190 | 185 | 8 | 49e09cdb843b3d889a06a811aa5affae68b25a75 | |
| ToppCell | COVID-19-T_cells|COVID-19 / group, cell type (main and fine annotations) | 1.40e-06 | 191 | 185 | 8 | 7f64add931b64b8d35836fa6bee9ebab593844d3 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 1.40e-06 | 191 | 185 | 8 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_NK-T_NK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.57e-06 | 194 | 185 | 8 | ec7e0ca6c9a2f63938e06ee771da09eff14fc3b5 | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_NK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.57e-06 | 194 | 185 | 8 | 5afe7f48d3383f3dac18765f97999c8b6936dc1b | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.64e-06 | 195 | 185 | 8 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.64e-06 | 195 | 185 | 8 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-06 | 195 | 185 | 8 | ffbab350e67d9c4b66c0ab84550daec8b8139a27 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.77e-06 | 197 | 185 | 8 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.83e-06 | 198 | 185 | 8 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | COVID_vent-Lymphocytic-ILC-NK_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.90e-06 | 199 | 185 | 8 | 5f914962e2572b0c6372465b81b7496fa663d93c | |
| ToppCell | COVID_vent-Lymphocytic-ILC|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.90e-06 | 199 | 185 | 8 | e3ff7fa1b1de1aaf6b46cdf49afa95bad457728a | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-NK-ILC|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.98e-06 | 200 | 185 | 8 | d2422aaf807010194994db97142b9fd2e807312d | |
| ToppCell | Sepsis-ICU-NoSEP-Lymphocyte-T/NK-NK_CD56bright|ICU-NoSEP / Disease, condition lineage and cell class | 1.98e-06 | 200 | 185 | 8 | c2df917900872453ea17a39928e39d071a6d3339 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK-NK_CD11d|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.98e-06 | 200 | 185 | 8 | bfbd2ccf4b28901aad63d70a382a8247e4458ba6 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.98e-06 | 200 | 185 | 8 | 1d2ee63010b7b8b38bea7d3b30eebfbcdd18b967 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.87e-06 | 160 | 185 | 7 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.87e-06 | 160 | 185 | 7 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | facs-Kidney-nan-3m-Lymphocytic|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.96e-06 | 165 | 185 | 7 | ba041deb0d9c187f251493ccd4794b5f09abd5aa | |
| ToppCell | LPS-antiTNF-Lymphocytic_NKT-iNKT/MAIT|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.44e-06 | 174 | 185 | 7 | 61aa89b56ebda0eba1ba675d5f036992967f670f | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)-D231|Adult / Lineage, Cell type, age group and donor | 8.76e-06 | 175 | 185 | 7 | 8d9f44a2633b71fb4d2b4a7d9530f954e07c4a18 | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)|Adult / Lineage, Cell type, age group and donor | 8.76e-06 | 175 | 185 | 7 | 4db1a3c284488b3f6de7568363f176d74e2a4587 | |
| ToppCell | LPS-antiTNF-Lymphocytic_NKT-iNKT/MAIT-iNKT-MAIT|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.76e-06 | 175 | 185 | 7 | 98cb577df466700e72d1bbc6689205ccf2e7fcba | |
| ToppCell | LPS-antiTNF|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.78e-06 | 178 | 185 | 7 | 289d1425c4e57fabcca994b27f9af1c0ce5d5bec | |
| ToppCell | ILEUM-non-inflamed-(5)_Plasma-(5)_IgM_plasma_cells|(5)_Plasma / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.09e-05 | 70 | 185 | 5 | aa63c1b77a9fb15e75835cb3781f2d890f3fe328 | |
| ToppCell | COVID-19-kidney-NK|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.09e-05 | 181 | 185 | 7 | 8906ee8a7a1616dfe8c3b5c73988416641213629 | |
| ToppCell | 21-Trachea-Epithelial-Multiciliated_precursor|Trachea / Age, Tissue, Lineage and Cell class | 1.13e-05 | 182 | 185 | 7 | 6e35892fa959ee31591850ded8f1088195ddeb01 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 1.17e-05 | 183 | 185 | 7 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | Control-Lymphocytic_NKT-iNKT/MAIT|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.17e-05 | 183 | 185 | 7 | 59e8d07556390828f7557ba3fd2f7d49851498b7 | |
| ToppCell | Control-Lymphocytic_NKT-iNKT/MAIT-iNKT-MAIT|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.17e-05 | 183 | 185 | 7 | 2c5707ada3442eb7100a2a5f9438d5a2ac53a9e1 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 1.17e-05 | 183 | 185 | 7 | cae2ee08f985a6f005b4b8e959e465350315156a | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-05 | 184 | 185 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-05 | 184 | 185 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-05 | 184 | 185 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.26e-05 | 185 | 185 | 7 | 45890fa81c65a48f4fdec164a4c8d0e2831243c0 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.26e-05 | 185 | 185 | 7 | 585bcfdff85bf43f5aa4cd1b39f7dcf1c78d7b02 | |
| ToppCell | COVID-19-kidney-FLT1+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.26e-05 | 185 | 185 | 7 | 673308ca0514a4d3629d61fe91e9d8fb31b72166 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-mature_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-05 | 186 | 185 | 7 | e23e1246914e230369a716d0d666b98383bf8512 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-BM_CD8_+_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-05 | 186 | 185 | 7 | 4dce1484653bb266e2305cbb306fb11eaf7892e2 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.39e-05 | 188 | 185 | 7 | 50c1b1d690f0e9443082f2adf4f1b8e9ce4cd337 | |
| ToppCell | COPD-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 1.39e-05 | 188 | 185 | 7 | 186fe1ea328c942910190a4240262c0d8642ea3b | |
| ToppCell | COVID-19-T_cells-CD8+_T_cells|COVID-19 / group, cell type (main and fine annotations) | 1.44e-05 | 189 | 185 | 7 | 2c018d6120f65f0b2704b483bc9da1c0984872e3 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.44e-05 | 189 | 185 | 7 | 7659c7bbd58ee959a159294fb8d17317bbcc5681 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-Neuronal-Interneuron|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 1.46e-05 | 126 | 185 | 6 | ec445ec097c9c45cd47b8cfa8c140df5b298695e | |
| ToppCell | COVID-19-kidney-NK|kidney / Disease (COVID-19 only), tissue and cell type | 1.49e-05 | 190 | 185 | 7 | e3ca3c9fb9e27670a5dd128dd6564ff98a57159e | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.49e-05 | 190 | 185 | 7 | d594da827e3c16644952b9589cc12b947ce36279 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_CD56bright-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.55e-05 | 191 | 185 | 7 | 7a4fe96989f72159385270c712342ba3e1ca6fc3 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_CD56bright|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.55e-05 | 191 | 185 | 7 | c023ca893ceae19b54967096f6e2588dc39fa268 | |
| ToppCell | Children_(3_yrs)-Immune-natural_killer_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.55e-05 | 191 | 185 | 7 | 6345c1aa0fd2f9f2154a44f9393bf7c72bb1f44e | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_CD56bright|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.55e-05 | 191 | 185 | 7 | f1935e8f8467a2bc30588b7f2cc3b94e9c83b268 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_CD56bright-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.55e-05 | 191 | 185 | 7 | 1161e465c50c2071764279e01cf08b1048cce0e3 | |
| ToppCell | COVID-19-lung-CD8+_T_cells|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.55e-05 | 191 | 185 | 7 | 543f8ae07cc2e6950c888115a5ca9445e3c0f618 | |
| ToppCell | Control-Lymphoid_T/NK-NK_CD56bright|Control / Disease group, lineage and cell class | 1.55e-05 | 191 | 185 | 7 | e842f29bc03ed6734b2a7b975e7830a498f2743c | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.65e-05 | 193 | 185 | 7 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | 10x5'-Liver|World / Manually curated celltypes from each tissue | 1.65e-05 | 193 | 185 | 7 | d010d47d763c99e68aede59345392f2a8c77d7ac | |
| ToppCell | COVID-19-kidney-T-cells-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.65e-05 | 193 | 185 | 7 | 5b84fa640cf30dea55fde53b810f850ff946d253 | |
| ToppCell | Children_(3_yrs)-Immune-natural_killer_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.65e-05 | 193 | 185 | 7 | 1cb666375bc4e1b11a146d20896c9b5ae6fd0887 | |
| ToppCell | COVID-19-kidney-FLT1+PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 1.65e-05 | 193 | 185 | 7 | 479abb1cd2eb978b8a4fdb900069a6329fc8cade | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.71e-05 | 194 | 185 | 7 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.71e-05 | 194 | 185 | 7 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.71e-05 | 194 | 185 | 7 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.71e-05 | 194 | 185 | 7 | d9eec28fa7b255c0ec023276dd955f1e276e7159 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.71e-05 | 194 | 185 | 7 | e4d7e9709ce42d4610e44d3445927eefbcbb9eff | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.74e-05 | 130 | 185 | 6 | 6434d9106ccb38786dad36fab80163dfc07b6eb7 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.77e-05 | 195 | 185 | 7 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | COVID-19-lung-NK/NKT|lung / Disease (COVID-19 only), tissue and cell type | 1.77e-05 | 195 | 185 | 7 | 3ab941a369e3815f338890b116dc77aefa054098 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK-NK_CD56bright|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.83e-05 | 196 | 185 | 7 | bbdc92ec2e95ed7d782df0c72d94f9a9d9439bf0 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-early_osteoblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.95e-05 | 198 | 185 | 7 | 6a539d3b47bd2d4a7ad5c67cad23facffc0ac45f | |
| ToppCell | (5)_Dendritic_cell-(52)_cycling_DCs|(5)_Dendritic_cell / shred on Cell_type and subtype | 2.01e-05 | 199 | 185 | 7 | d0ff446a197062b10f37b585f3f8716d6d89e5b7 | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 2.01e-05 | 199 | 185 | 7 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | COVID_non-vent-Lymphocytic-ILC-NK_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.01e-05 | 199 | 185 | 7 | ed35d747f11f6ea6a5cb7061057f0a98d9e0db99 | |
| ToppCell | COVID_non-vent-Lymphocytic-ILC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.01e-05 | 199 | 185 | 7 | df4f7d5be099e3e6054f3b812ccf70251664e4c0 | |
| ToppCell | Severe-Lymphoid-T-Proliferating_T|Severe / Condition, Lineage, Cell class and cell subclass | 2.08e-05 | 200 | 185 | 7 | 266270c756fb69945449ce02da04743cd31f8158 | |
| ToppCell | Tracheal|World / Cell types per location group and 10X technology with lineage, and cell group designations | 2.08e-05 | 200 | 185 | 7 | 682960e28542a3d6c119047cd0131941932cfdea | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK-NK|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.08e-05 | 200 | 185 | 7 | 7d90fcb5dfc4c9d562c93b0f9293ed12b5f4f404 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-NK-ILC|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.08e-05 | 200 | 185 | 7 | 56d738ff019682af7f1f8cbe7b262a75dc8596d5 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.08e-05 | 200 | 185 | 7 | 7eed3d932018d6a87ce37d013883b371db55caeb | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26-Neuronal-GABAergic_neurons|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 2.08e-05 | 200 | 185 | 7 | bad32a95b759fad509401b07bc96a56687c2a592 | |
| ToppCell | COVID-19-Heart-CM_5_(RYR2-)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.10e-05 | 144 | 185 | 6 | f92e03dd784e31a9e5dbd4f4c3a6517ea19210cf | |
| ToppCell | COVID-19-Heart-CM_5_(RYR2-)|Heart / Disease (COVID-19 only), tissue and cell type | 4.69e-05 | 155 | 185 | 6 | d7e26696fd9c0a759524f331243db43059b33ed9 | |
| Drug | halothane | CACNA1B CACNA1C CACNA2D1 GRIA1 PKD1L3 ZZEF1 CHRM1 IFNA4 IFNA5 IFNA6 IFNA7 RYR3 CHRND IFNA17 PRKCB PYGM GABRA4 | 6.22e-10 | 314 | 181 | 17 | CID000003562 |
| Drug | tilorone | 9.95e-09 | 35 | 181 | 7 | CID000005475 | |
| Drug | isofagomine lactam | 2.22e-08 | 39 | 181 | 7 | CID000448980 | |
| Drug | gunacin | 5.68e-08 | 14 | 181 | 5 | CID000198547 | |
| Drug | pppA2'-5'A2'-5'A | 8.46e-08 | 15 | 181 | 5 | CID000125229 | |
| Drug | adefovir dipivoxil | 1.16e-07 | 49 | 181 | 7 | CID000060871 | |
| Drug | Yfrkd | 1.33e-07 | 7 | 181 | 4 | CID000129984 | |
| Drug | dideoxyinosine | 1.46e-07 | 75 | 181 | 8 | CID000003043 | |
| Drug | trifluorothymidine | 1.54e-07 | 51 | 181 | 7 | CID000006256 | |
| Drug | podophyllin | 2.37e-07 | 18 | 181 | 5 | CID011979494 | |
| Drug | Nyco | 2.37e-07 | 18 | 181 | 5 | CID000071618 | |
| Drug | 1hiv | 2.64e-07 | 8 | 181 | 4 | CID005479205 | |
| Drug | Chebi:36708 | 2.64e-07 | 8 | 181 | 4 | CID011966289 | |
| Drug | EN-1530 | CACNA2D1 GRIA1 CHRM1 IFNA4 IFNA5 IFNA6 IFNA7 IFNA17 ADH1B ADH1C TH PLS3 GABRA4 | 3.78e-07 | 278 | 181 | 13 | CID000004425 |
| Drug | isoflurane | CACNA1C CACNA2D1 GRIA1 ZZEF1 CHRM1 IFNA4 IFNA5 IFNA6 IFNA7 RYR3 CHRND IFNA17 GABRA4 | 3.93e-07 | 279 | 181 | 13 | CID000003763 |
| Drug | 4-Iodopyrazole | 4.94e-07 | 3 | 181 | 3 | DB02721 | |
| Drug | fotemustine | 5.19e-07 | 38 | 181 | 6 | CID000104799 | |
| Drug | IAA-94 | 5.43e-07 | 61 | 181 | 7 | CID000003667 | |
| Drug | acyclovir | 6.73e-07 | 124 | 181 | 9 | CID000002022 | |
| Drug | formosanin C | 7.09e-07 | 22 | 181 | 5 | CID000073597 | |
| Drug | pipobroman | 7.82e-07 | 10 | 181 | 4 | CID000004842 | |
| Drug | Hiltonol | 9.00e-07 | 23 | 181 | 5 | CID000431963 | |
| Drug | ethanol | CACNA1B CACNA1C INSR GRIA1 APOA1 CHRM1 IFNA4 IFNA5 IFNA6 IFNA7 CHRND IFNA17 ADH1A ADH1B ADH1C JAK1 LIFR TH PRKCB FTL FH GABRA4 | 9.16e-07 | 837 | 181 | 22 | CID000000702 |
| Drug | copolymer 1 | 9.37e-07 | 66 | 181 | 7 | CID003081884 | |
| Drug | cycloferon | 1.13e-06 | 24 | 181 | 5 | CID000038072 | |
| Drug | flesinoxan | 1.22e-06 | 11 | 181 | 4 | CID000057347 | |
| Drug | hycanthone | 1.40e-06 | 25 | 181 | 5 | CID000003634 | |
| Drug | AC1L9AL3 | 1.67e-06 | 46 | 181 | 6 | CID000441122 | |
| Drug | ABMP | 1.73e-06 | 26 | 181 | 5 | CID000080567 | |
| Drug | entecavir | 1.90e-06 | 47 | 181 | 6 | CID000153941 | |
| Drug | Fomepizole | 1.97e-06 | 4 | 181 | 3 | DB01213 | |
| Drug | inosiplex | 2.10e-06 | 27 | 181 | 5 | CID000037510 | |
| Drug | AC1L1GVK | 2.46e-06 | 76 | 181 | 7 | CID000003860 | |
| Drug | R 842 | 2.61e-06 | 13 | 181 | 4 | CID000130714 | |
| Drug | AC1O52EF | 2.61e-06 | 13 | 181 | 4 | CID006450817 | |
| Drug | Leucine enkephalin | 2.62e-06 | 109 | 181 | 8 | CID000003903 | |
| Drug | NSC105014 | 2.81e-06 | 110 | 181 | 8 | CID000001546 | |
| Drug | bromcresol green | 2.81e-06 | 110 | 181 | 8 | CID000006451 | |
| Drug | NSC-163039 | 3.04e-06 | 190 | 181 | 10 | CID000005064 | |
| Drug | Lanicemine | 3.63e-06 | 14 | 181 | 4 | CID003038485 | |
| Drug | DZNep | 3.64e-06 | 30 | 181 | 5 | CID000073087 | |
| Drug | poly rI:rC | 3.64e-06 | 30 | 181 | 5 | CID011979660 | |
| Drug | procaine | CACNA1B CACNA1C CACNA2D1 PKD1L3 CHRM1 RYR3 CHRND PRKCB GABRA4 | 3.88e-06 | 153 | 181 | 9 | CID000004914 |
| Drug | resiquimod | 3.92e-06 | 115 | 181 | 8 | CID000159603 | |
| Drug | hydroxyachillin | 4.88e-06 | 5 | 181 | 3 | CID000099114 | |
| Drug | CHEMBL466993 | 5.08e-06 | 32 | 181 | 5 | CID005320808 | |
| Drug | CNS 1145 | 5.95e-06 | 33 | 181 | 5 | CID000190902 | |
| Drug | IHC-64 | 5.95e-06 | 33 | 181 | 5 | CID000162753 | |
| Drug | L-lysyl-L-lysyl-L-lysine | 6.19e-06 | 162 | 181 | 9 | CID000072363 | |
| Drug | Lps2 | 6.67e-06 | 58 | 181 | 6 | CID000454710 | |
| Drug | carprofen | 6.93e-06 | 34 | 181 | 5 | CID000002581 | |
| Drug | oxymatrine | 6.93e-06 | 34 | 181 | 5 | CID000114850 | |
| Drug | tenofovir disoproxil fumarate | 6.93e-06 | 34 | 181 | 5 | CID005481350 | |
| Drug | lobucavir | 8.04e-06 | 35 | 181 | 5 | CID000060786 | |
| Drug | pimozide | 8.19e-06 | 127 | 181 | 8 | CID000016362 | |
| Drug | YNK01 | 8.48e-06 | 17 | 181 | 4 | CID000084071 | |
| Drug | imatinib | HSP90B1 FLT4 INSR IFNA4 IFNA5 IFNA6 IFNA7 IFNA17 JAK1 LIFR IGF1R MAGEC2 PLS3 EPHA1 | 9.43e-06 | 430 | 181 | 14 | CID000005291 |
| Drug | sunitinib | 9.72e-06 | 130 | 181 | 8 | CID005329102 | |
| Drug | ruthenium | 1.02e-05 | 94 | 181 | 7 | CID000023950 | |
| Drug | pyran | 1.07e-05 | 37 | 181 | 5 | CID000033703 | |
| Drug | FMAU | 1.07e-05 | 37 | 181 | 5 | CID000072327 | |
| Drug | p203 | 1.08e-05 | 18 | 181 | 4 | CID000019228 | |
| Drug | lercanidipine | 1.08e-05 | 63 | 181 | 6 | CID000065866 | |
| Drug | 5-FU | NRIP1 DRAM1 CPE RRM1 RRM2 IFNA4 IFNA5 IFNA6 IFNA7 IFNA17 SLC12A2 PRKCB PYGM MVP MAD2L1 KDM4B | 1.16e-05 | 562 | 181 | 16 | CID000003385 |
| Drug | adefovir | 1.19e-05 | 64 | 181 | 6 | CID000060172 | |
| Drug | sulfate | HEXA HEXB CACNA1C CACNA2D1 ABCC4 INSR PELI2 GRIA1 SPA17 CHRM1 IFNA4 IFNA5 IFNA6 IFNA7 CHRND IFNA17 IGF1R PRKCB CCL3 CCL5 FTL RP2 CPVL PLS3 CAP2 ADSS1 | 1.20e-05 | 1292 | 181 | 26 | CID000001117 |
| Drug | anagrelide | 1.22e-05 | 38 | 181 | 5 | CID000002182 | |
| Drug | AC1Q5THZ | HEXA HEXB CACNA2D1 HSP90B1 CHRM1 IFNA4 IFNA5 IFNA6 IFNA7 IFNA17 FCGR3A GUCY2C PRKCB PYGM PLS3 | 1.25e-05 | 502 | 181 | 15 | CID000001959 |
| Drug | MeSAdo | 1.43e-05 | 137 | 181 | 8 | CID000000149 | |
| Drug | nitric oxide | HEXA HEXB IL12RB2 CACNA2D1 GRIA1 RRM1 RRM2 CHRM1 PANX3 IFNA4 IFNA5 IFNA6 IFNA7 RYR3 IFNA17 TH SLC12A2 GUCY2C PRKCB CCL3 CCL5 FTL PLS3 | 1.55e-05 | 1075 | 181 | 23 | CID000145068 |
| Drug | Amlodipine | 1.69e-05 | 7 | 181 | 3 | DB00381 | |
| Drug | Ethanol | 1.69e-05 | 7 | 181 | 3 | DB00898 | |
| Drug | leucodin | 1.69e-05 | 7 | 181 | 3 | CID000167683 | |
| Drug | vindesine | 1.69e-05 | 68 | 181 | 6 | CID000040839 | |
| Drug | Ciluprevir [USAN] | 1.69e-05 | 20 | 181 | 4 | CID006450803 | |
| Drug | val-mCyd | 1.69e-05 | 20 | 181 | 4 | CID006918726 | |
| Drug | cycloleucine | 1.84e-05 | 69 | 181 | 6 | CID000002901 | |
| Drug | 1 ind | 2.01e-05 | 42 | 181 | 5 | CID003037877 | |
| Drug | Ethylene Glycol | 2.08e-05 | 21 | 181 | 4 | ctd:D019855 | |
| Drug | 4-iodopyrazole | 2.08e-05 | 21 | 181 | 4 | CID000077022 | |
| Drug | L DO | 2.08e-05 | 21 | 181 | 4 | CID000097725 | |
| Drug | vinblastine | 2.13e-05 | 189 | 181 | 9 | CID000013342 | |
| Drug | 9-cis-acitretin | 2.17e-05 | 71 | 181 | 6 | CID000041317 | |
| Drug | N6-methyl-(R)-roscovitine | 2.17e-05 | 71 | 181 | 6 | CID005289296 | |
| Drug | Sesquimustard | 2.26e-05 | 43 | 181 | 5 | CID000019092 | |
| Drug | pemetrexed | 2.35e-05 | 72 | 181 | 6 | CID000060843 | |
| Drug | Thapsigargin | DHX36 UBR2 CACNA2D1 HSP90B1 FLT4 USE1 BCLAF1 NECTIN3 RRM1 RRM2 CHRM1 TRIP12 JAK1 PREP CTR9 YLPM1 MLF1 PRKCB CCL3 MPHOSPH6 FH DSCC1 MVP PLS3 FKBP3 MAD2L1 | 2.66e-05 | 1353 | 181 | 26 | ctd:D019284 |
| Drug | Flunarizine | 2.69e-05 | 8 | 181 | 3 | ctd:D005444 | |
| Drug | N-heptylformamide | 2.69e-05 | 8 | 181 | 3 | CID000347402 | |
| Drug | AC1L1GHH | 2.75e-05 | 74 | 181 | 6 | CID000003685 | |
| Drug | genistein | CACNA1B CACNA1C CACNA2D1 ABCC4 INSR APOA1 PKD1L3 IFNA4 IFNA5 IFNA7 RYR3 IFNA17 JAK1 IGF1R SLC12A2 FCGR3A MLF1 PRKCB CCL5 GREB1 PLS3 DYNC1H1 GABRA4 | 2.82e-05 | 1117 | 181 | 23 | CID005280961 |
| Drug | morphine hydrochloride | CACNA1B CACNA2D1 INSR GRIA1 CHRM1 IFNA4 IFNA5 IFNA6 IFNA7 IFNA17 TH CCL3 CCL5 GABRA4 | 3.26e-05 | 481 | 181 | 14 | CID000004253 |
| Drug | AC1MMF4B | 3.45e-05 | 77 | 181 | 6 | CID003260010 | |
| Drug | NSC-218321 | 3.59e-05 | 114 | 181 | 7 | CID000004739 | |
| Drug | AC1L1ZCT | 3.63e-05 | 24 | 181 | 4 | CID000038235 | |
| Drug | L-Ft | 3.71e-05 | 78 | 181 | 6 | CID000451514 | |
| Drug | cyclophorine | CACNA1B CACNA1C IL12RB2 CACNA2D1 ABCC4 PPIL6 APOA1 PKD1L3 RYR3 PRKCB CCL5 MVP FKBP3 | 3.87e-05 | 426 | 181 | 13 | CID000002909 |
| Drug | N-cyclopentyl-N-cyclobutylformamide | 3.99e-05 | 79 | 181 | 6 | CID005287890 | |
| Drug | 2-NA | 4.01e-05 | 9 | 181 | 3 | CID000074128 | |
| Drug | (3R,7R)-17-(6-hydroxy-1,5-dimethyl-hexyl)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-3,7-diol | 4.01e-05 | 9 | 181 | 3 | CID000440672 | |
| Disease | Sclerocystic Ovaries | 2.80e-06 | 144 | 178 | 8 | C1136382 | |
| Disease | Polycystic Ovary Syndrome | 2.80e-06 | 144 | 178 | 8 | C0032460 | |
| Disease | alcohol use disorder measurement, alcohol consumption measurement | 2.78e-05 | 97 | 178 | 6 | EFO_0007878, EFO_0009458 | |
| Disease | Lambert-Eaton myasthenic syndrome (is_implicated_in) | 3.62e-05 | 2 | 178 | 2 | DOID:0050214 (is_implicated_in) | |
| Disease | Congenital hernia of foramen of Morgagni | 1.95e-04 | 19 | 178 | 3 | C0265699 | |
| Disease | Congenital hernia of foramen of Bochdalek | 1.95e-04 | 19 | 178 | 3 | C0265700 | |
| Disease | multiple sclerosis (is_marker_for) | 2.19e-04 | 49 | 178 | 4 | DOID:2377 (is_marker_for) | |
| Disease | mouth morphology measurement | 2.37e-04 | 50 | 178 | 4 | EFO_0007955 | |
| Disease | asthma exacerbation measurement, response to corticosteroid | 2.56e-04 | 51 | 178 | 4 | EFO_0007614, GO_0031960 | |
| Disease | epilepsy (biomarker_via_orthology) | 2.65e-04 | 21 | 178 | 3 | DOID:1826 (biomarker_via_orthology) | |
| Disease | Congenital diaphragmatic hernia | 2.65e-04 | 21 | 178 | 3 | C0235833 | |
| Disease | chronic obstructive pulmonary disease | EFCAB5 FRAS1 HIVEP2 ARHGEF28 DSP DOCK10 PELI2 PELI1 VARS2 KCNQ5 DLEC1 KIF13A ARAP2 | 2.96e-04 | 688 | 178 | 13 | EFO_0000341 |
| Disease | Lewy Body Disease | 3.05e-04 | 22 | 178 | 3 | C0752347 | |
| Disease | age at onset, Myopia | 3.09e-04 | 150 | 178 | 6 | EFO_0004847, HP_0000545 | |
| Disease | Alcohol dependence | 3.58e-04 | 5 | 178 | 2 | cv:C0001973 | |
| Disease | gestational diabetes (biomarker_via_orthology) | 3.58e-04 | 5 | 178 | 2 | DOID:11714 (biomarker_via_orthology) | |
| Disease | ALCOHOL DEPENDENCE | 3.58e-04 | 5 | 178 | 2 | 103780 | |
| Disease | Psychotic Disorders | 3.75e-04 | 101 | 178 | 5 | C0033975 | |
| Disease | Intellectual Disability | 4.09e-04 | 447 | 178 | 10 | C3714756 | |
| Disease | MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE | 5.34e-04 | 6 | 178 | 2 | C1854678 | |
| Disease | COVID-19 (is_marker_for) | 5.78e-04 | 63 | 178 | 4 | DOID:0080600 (is_marker_for) | |
| Disease | hypertension | 5.81e-04 | 307 | 178 | 8 | EFO_0000537 | |
| Disease | triacylglycerol 54:7 measurement | 6.33e-04 | 28 | 178 | 3 | EFO_0010425 | |
| Disease | body weight | CACNA1B CACNA1C HIVEP2 AZGP1 INSR ARHGEF12 ZZEF1 DCUN1D4 TRIP12 DNAH14 ADH1B TRIM66 IGF1R SLC12A2 KCNQ5 DNA2 CPVL KDM4B | 6.50e-04 | 1261 | 178 | 18 | EFO_0004338 |
| Disease | non-alcoholic fatty liver disease (biomarker_via_orthology) | 6.51e-04 | 65 | 178 | 4 | DOID:0080208 (biomarker_via_orthology) | |
| Disease | Movement Disorders | 7.03e-04 | 29 | 178 | 3 | C0026650 | |
| Disease | common carotid intimal medial thickness | 7.30e-04 | 67 | 178 | 4 | EFO_0004860 | |
| Disease | osteoporosis (is_implicated_in) | 8.57e-04 | 31 | 178 | 3 | DOID:11476 (is_implicated_in) | |
| Disease | Hyperkinesia | 9.41e-04 | 32 | 178 | 3 | C3887506 | |
| Disease | triacylglycerol 54:5 measurement | 9.41e-04 | 32 | 178 | 3 | EFO_0010423 | |
| Disease | Hyperkinesia, Generalized | 9.41e-04 | 32 | 178 | 3 | C0751217 | |
| Disease | Alzheimer's disease (is_marker_for) | 9.89e-04 | 257 | 178 | 7 | DOID:10652 (is_marker_for) | |
| Disease | Sudden Cardiac Death | 9.89e-04 | 8 | 178 | 2 | C0085298 | |
| Disease | Liver carcinoma | 1.07e-03 | 507 | 178 | 10 | C2239176 | |
| Disease | Colorectal Carcinoma | ABCC4 CPE CBFA2T3 RRM2 ADH1B LIFR KCNQ5 GUCY2C LMO7 CHD5 PRKCB EPHA1 | 1.20e-03 | 702 | 178 | 12 | C0009402 |
| Disease | retinal detachment, retinal break | 1.23e-03 | 35 | 178 | 3 | EFO_0005773, EFO_0010698 | |
| Disease | alcohol dependence (implicated_via_orthology) | 1.27e-03 | 9 | 178 | 2 | DOID:0050741 (implicated_via_orthology) | |
| Disease | non-alcoholic fatty liver disease (implicated_via_orthology) | 1.33e-03 | 36 | 178 | 3 | DOID:0080208 (implicated_via_orthology) | |
| Disease | alcohol use disorder measurement, longitudinal alcohol consumption measurement | 1.44e-03 | 37 | 178 | 3 | EFO_0007645, EFO_0009458 | |
| Disease | Colorectal Neoplasms | 1.52e-03 | 277 | 178 | 7 | C0009404 | |
| Disease | gestational age | 1.53e-03 | 138 | 178 | 5 | EFO_0005112 | |
| Disease | alopecia areata (is_marker_for) | 1.58e-03 | 10 | 178 | 2 | DOID:986 (is_marker_for) | |
| Disease | ankyrin-2 measurement | 1.58e-03 | 10 | 178 | 2 | EFO_0021874 | |
| Disease | human immunodeficiency virus infectious disease (is_implicated_in) | 1.68e-03 | 39 | 178 | 3 | DOID:526 (is_implicated_in) | |
| Disease | body surface area | DRAM1 INSR ARHGEF12 ZC3H11B GRIA1 RRM2 DCUN1D4 TRIP12 TRIM66 IGF1R DLEC1 | 1.90e-03 | 643 | 178 | 11 | EFO_0022196 |
| Disease | Shortened QT interval | 1.92e-03 | 11 | 178 | 2 | C0151879 | |
| Disease | sleep disorder (implicated_via_orthology) | 1.92e-03 | 11 | 178 | 2 | DOID:535 (implicated_via_orthology) | |
| Disease | hippocampal CA4 volume | 1.94e-03 | 41 | 178 | 3 | EFO_0009396 | |
| Disease | response to anticoagulant | 1.94e-03 | 41 | 178 | 3 | GO_0061476 | |
| Disease | pulse pressure measurement | NRIP1 FAT3 INSR ARHGEF12 ZC3H11B PKD1L3 TRIM59 ADH1B ADH1C TRIM66 TTBK1 PBRM1 SLC12A2 KCNQ5 SUPT6H DLEC1 BRD1 KDM4B | 1.96e-03 | 1392 | 178 | 18 | EFO_0005763 |
| Disease | Seizures | 2.15e-03 | 218 | 178 | 6 | C0036572 | |
| Disease | quality of life during menstruation measurement, decreased attention | 2.30e-03 | 12 | 178 | 2 | EFO_0009366, NCIT_C117245 | |
| Disease | Myopia | 2.44e-03 | 385 | 178 | 8 | HP_0000545 | |
| Disease | prostate cancer (is_marker_for) | 2.62e-03 | 156 | 178 | 5 | DOID:10283 (is_marker_for) | |
| Disease | Squamous cell carcinoma of esophagus | 2.66e-03 | 95 | 178 | 4 | C0279626 | |
| Disease | Celiac Disease | 2.88e-03 | 47 | 178 | 3 | C0007570 | |
| Disease | IGF-1 measurement | 2.96e-03 | 488 | 178 | 9 | EFO_0004627 | |
| Disease | triacylglycerol 48:4 measurement | 3.14e-03 | 14 | 178 | 2 | EFO_0010407 | |
| Disease | diabetic neuropathy (implicated_via_orthology) | 3.14e-03 | 14 | 178 | 2 | DOID:9743 (implicated_via_orthology) | |
| Disease | epilepsy (implicated_via_orthology) | 3.16e-03 | 163 | 178 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | FEV/FEC ratio | EFCAB5 FRAS1 HIVEP2 ARHGEF28 DSP ZC3H11B NEB RRM2 KCNQ5 FCGR3A HHAT YLPM1 DLEC1 KIF13A CPVL ARAP2 | 3.24e-03 | 1228 | 178 | 16 | EFO_0004713 |
| Disease | gastroesophageal reflux disease | 3.32e-03 | 101 | 178 | 4 | EFO_0003948 | |
| Disease | amyotrophic lateral sclerosis, age at onset | 3.61e-03 | 15 | 178 | 2 | EFO_0004847, MONDO_0004976 | |
| Disease | hepatic encephalopathy (biomarker_via_orthology) | 3.61e-03 | 15 | 178 | 2 | DOID:13413 (biomarker_via_orthology) | |
| Disease | age-related hearing impairment | 3.64e-03 | 324 | 178 | 7 | EFO_0005782 | |
| Disease | substance-related disorder | 3.84e-03 | 52 | 178 | 3 | MONDO_0002494 | |
| Disease | alcohol use disorder (is_implicated_in) | 4.11e-03 | 16 | 178 | 2 | DOID:1574 (is_implicated_in) | |
| Disease | – | 4.11e-03 | 16 | 178 | 2 | 609423 | |
| Disease | Susceptibility to HIV infection | 4.11e-03 | 16 | 178 | 2 | cv:C1836230 | |
| Disease | Metastatic melanoma | 4.27e-03 | 54 | 178 | 3 | C0278883 | |
| Disease | Prostatic Neoplasms | HSP90B1 ABCC4 DCAF6 AZGP1 JAK1 LIFR SLC12A2 STARD3 ENPP5 GREB1 | 4.37e-03 | 616 | 178 | 10 | C0033578 |
| Disease | Malignant neoplasm of prostate | HSP90B1 ABCC4 DCAF6 AZGP1 JAK1 LIFR SLC12A2 STARD3 ENPP5 GREB1 | 4.37e-03 | 616 | 178 | 10 | C0376358 |
| Disease | alcohol dependence measurement | 4.50e-03 | 55 | 178 | 3 | EFO_0007835 | |
| Disease | S-adenosylhomocysteine measurement | 4.64e-03 | 17 | 178 | 2 | EFO_0010531 | |
| Disease | cyclic adenosine monophosphate measurement | 4.64e-03 | 17 | 178 | 2 | EFO_0010473 | |
| Disease | triacylglycerol 56:9 measurement | 4.64e-03 | 17 | 178 | 2 | EFO_0010436 | |
| Disease | hypertrophic cardiomyopathy (is_marker_for) | 4.64e-03 | 17 | 178 | 2 | DOID:11984 (is_marker_for) | |
| Disease | non-alcoholic steatohepatitis (biomarker_via_orthology) | 4.64e-03 | 17 | 178 | 2 | DOID:0080547 (biomarker_via_orthology) | |
| Disease | acute kidney failure (is_marker_for) | 4.64e-03 | 17 | 178 | 2 | DOID:3021 (is_marker_for) | |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 4.64e-03 | 17 | 178 | 2 | DOID:0060307 (is_implicated_in) | |
| Disease | Autistic Disorder | 5.19e-03 | 261 | 178 | 6 | C0004352 | |
| Disease | Adrenocortical carcinoma | 5.20e-03 | 18 | 178 | 2 | C0206686 | |
| Disease | ankle injury | 5.48e-03 | 59 | 178 | 3 | EFO_1002021 | |
| Disease | sensorineural hearing loss (implicated_via_orthology) | 5.78e-03 | 19 | 178 | 2 | DOID:10003 (implicated_via_orthology) | |
| Disease | Hypertensive disease | 6.03e-03 | 190 | 178 | 5 | C0020538 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RIYPDSIQELEVWKK | 201 | A0A0G2JMD5 | |
| LDIPEEEARYWAKKL | 131 | Q9UPW8 | |
| EKFETLRENSWVKDP | 526 | P0CF97 | |
| QESKIRYKTNEPVWE | 571 | A0FGR8 | |
| TDVDREDKLWLKPYV | 586 | P21709 | |
| PVLLDEFVEWYKDKQ | 276 | Q92564 | |
| DAKENRTYPVEWIII | 186 | Q07001 | |
| EDYAWLEIVNEKRKG | 161 | O95696 | |
| EYQYKKDEVWEERKP | 306 | P12645 | |
| KDEVWEERKPYKTLQ | 311 | P12645 | |
| LWDEPSVEVTYLKKQ | 141 | Q8N129 | |
| REIIKQEENVDPDYW | 1306 | Q8TDI0 | |
| WEELPEVVRKDYGKK | 261 | Q02338 | |
| WELKKPFSIEEVEVA | 16 | P07327 | |
| WEVKKPFSIEDVEVA | 16 | P00325 | |
| WELKKPFSIEEVEVA | 16 | P00326 | |
| LDPERKLEKAWAYCE | 151 | A6NHR8 | |
| KVEDIWIPREDKNNF | 391 | Q8WZ64 | |
| PWDRVKDLATVYVDV | 31 | P02647 | |
| KWQEEMELYRQKVEP | 131 | P02647 | |
| IDYDIKIWSPLEESR | 781 | Q58WW2 | |
| WPEVICLEVYEKSKR | 541 | Q6DHV5 | |
| DNVVRKYAKRITEWP | 81 | Q00975 | |
| KEEVEAQPRQWKKYD | 1331 | Q00975 | |
| NIAKYTEWPTEREKV | 946 | Q9NZN5 | |
| VIPSEYWVEEKEEKQ | 376 | Q13434 | |
| KLKEIVYPSIDEARW | 386 | Q13613 | |
| YLLVKNCWEEDPEKR | 721 | P25092 | |
| KLWYAPNRTITVDDK | 86 | P23458 | |
| KDHPYTWRIELAKTE | 281 | Q9Y570 | |
| NRIQEEEWDKYIIPA | 596 | Q8N1W1 | |
| EEWDKYIIPAKSESE | 601 | Q8N1W1 | |
| ISITKLEWNPREKDY | 181 | Q8N682 | |
| WKILGNEETKREYDL | 66 | Q6P3W2 | |
| WLEEYKVRQKAGLEA | 96 | O94952 | |
| IEPLNEFKAVKDWEI | 221 | Q6NXN4 | |
| EWRNLETAKKAEYEE | 1416 | Q86U86 | |
| EKKYSPCAWEVVRAE | 156 | P01570 | |
| TEDEPTLEFDKKIYW | 2666 | Q86XX4 | |
| KEQADFLPRIEETKW | 426 | O60299 | |
| YTDKDLVVPEKWEES | 156 | Q13257 | |
| SWYKDALKDVEERVQ | 331 | Q9UBF1 | |
| YRNEFRAWTDIKPVK | 301 | Q96JE9 | |
| PEEEYTKQNLKRLWV | 196 | Q4G0X4 | |
| KIEDVEWRPQTYLEL | 1006 | Q4ZG55 | |
| EQEEYKREGIPWTKV | 416 | Q9UBC5 | |
| KREGIPWTKVDYFDN | 421 | Q9UBC5 | |
| RALFQDIKKPAEDEW | 76 | P02792 | |
| AIWAEVEKEPEKYPL | 1066 | Q9Y3R5 | |
| YPKWRESKLFITDEE | 861 | Q9NR82 | |
| KDPSAVQEYVVEWRE | 446 | Q99665 | |
| EKKYSPCAWEVVRAE | 156 | P01568 | |
| PWFREEEVQYIQAEK | 31 | O95786 | |
| ELEGKKWRVEYQEDR | 326 | P40123 | |
| EKYLREDTVQSVKPW | 356 | Q9H3G5 | |
| EKKYSPCAWEVVRAE | 156 | P01562 | |
| VYVPDEWEVAREKIT | 986 | P08069 | |
| WEHLEILQKEDVKPY | 126 | P14921 | |
| DEKWKEAILQEKPYL | 1066 | Q63HM2 | |
| QLYERIKVPVDWSKV | 431 | P13797 | |
| KVYRDFINIPEEWQE | 106 | Q8IXQ8 | |
| EEWQEIYDLIPEAKF | 116 | Q8IXQ8 | |
| PNLTVYKKEDVPERW | 291 | Q9UJA9 | |
| EKKYSPCAWEVVRAE | 156 | P01569 | |
| EKKYSPCAWEVVRAE | 156 | P01567 | |
| EELIEWIKYSTKPDA | 536 | Q2PZI1 | |
| KEWKPRASYDDIDDL | 51 | O75164 | |
| PKEWKPRQTYDDIDD | 51 | O94953 | |
| IIPPKEWKARETYDN | 51 | Q6B0I6 | |
| TPEDVNWKRIKRETY | 426 | Q8WWI1 | |
| AWKYNGDVEDIKRTP | 936 | Q8WWI1 | |
| PIKWVITDAEKNEYE | 1041 | P48552 | |
| LEEKKQVEWDYKLVP | 451 | Q96PP9 | |
| QTWIDKRLKYDGPIE | 101 | P48169 | |
| LYVWDLEVEDPHKAK | 386 | O75530 | |
| RYIDWEKLERKEIQP | 601 | P05771 | |
| YVPDEWEVSREKITL | 1011 | P06213 | |
| IYWERERKPKTEEFP | 1161 | Q6IE36 | |
| YVPEDIWRKAEEAVN | 481 | O75081 | |
| EVWDIVDIKPSALYD | 111 | Q8IXY8 | |
| YMLTQDEVLWEKELP | 406 | Q14764 | |
| LEWLNTEEPISVYKD | 61 | Q8NBF2 | |
| DCDPVYKVATWEKQI | 361 | Q9BRP4 | |
| QVFWEEAKKREDPVT | 1706 | Q7Z442 | |
| RPWIVDEKKDDGYTA | 621 | Q86YT6 | |
| PYVFWNELEKARKER | 171 | Q96QZ0 | |
| GVEEVKRRWYKTENE | 151 | Q5VTY9 | |
| ERVIEYTDLEKEAPW | 1011 | O15439 | |
| IDFRDPEESKWKVLV | 316 | P48147 | |
| DKKHEYWFAVPQERT | 586 | Q8N573 | |
| PIWQRPSKEVEEDEY | 341 | P14625 | |
| EYIEVPLQEKRSWEQ | 691 | A4FU69 | |
| IDVVEKYDPKTQEWS | 296 | Q53G59 | |
| ERYDPKENKWTRVAS | 431 | Q9Y2M5 | |
| SIEKYDPDLNKWEIV | 526 | Q8NBE8 | |
| NWQRYPRTKVEEKEA | 266 | Q8WZ55 | |
| EKWTEEDIAPYIQDL | 346 | Q9BVC3 | |
| KRIWAEYDPEAKGRI | 1546 | Q13936 | |
| WKSERYELIADVNKP | 1821 | Q96BY6 | |
| VVTYEEKPREQWILD | 1676 | Q9UFH2 | |
| EVFKKNREEDPSLLW | 191 | P54289 | |
| YLTAEQFDEWVKPKD | 491 | P07954 | |
| EKEEKEAIYKERWPD | 431 | Q9H2U1 | |
| PDWKVVQDYLEILEF | 61 | Q8TF46 | |
| FQKRPKEEEWDPEYT | 826 | Q9NYF8 | |
| EAVKEKWLPYEAGQR | 2711 | P15924 | |
| IKERKQIDWESFPYG | 326 | Q8TDW7 | |
| EWKVYVKRPLDREEQ | 2981 | Q8TDW7 | |
| EKARLEIEPEWAYGK | 186 | Q00688 | |
| LVGQDEIWKYRLKAE | 16 | Q9H1P6 | |
| LKKVTEQYPDDVEAW | 401 | Q6PD62 | |
| EKFPPEETLKTYWED | 346 | P16870 | |
| PRLLQAYSWKEEEEE | 266 | P11229 | |
| PEKKWVREYINSLEM | 76 | P13501 | |
| PSEEWVQKYVSDLEL | 76 | P10147 | |
| KDIEKRDENTWYPEK | 1741 | Q0VDD8 | |
| WLSKDYIPVDQEELR | 2876 | Q14204 | |
| KWTVYREPGVEQDKI | 391 | Q96PD2 | |
| TEGVTAYEEKPREQW | 1696 | Q9NYC9 | |
| IEADEENLKETRWPY | 476 | Q3B820 | |
| IRKIGYWNEDDKFVP | 376 | P42261 | |
| EPQWYRVLEKDSVTL | 31 | P08637 | |
| VEVWKDSAYPEELSR | 421 | P07686 | |
| DIRLDWETYVPEDKE | 1286 | Q9Y238 | |
| WETYVPEDKEDRLVE | 1291 | Q9Y238 | |
| WEEAELPAELFQKKV | 16 | P51530 | |
| EFLLEPEDYKRWIEI | 1651 | Q6ZTR5 | |
| EKKYSPCAWEVVRAE | 156 | P01571 | |
| FLEKYKRPVCDTDQW | 326 | Q8IZK6 | |
| EEPEEVQYKKSTAWL | 921 | Q5VW36 | |
| KREWIKETFYPDIPN | 861 | P42702 | |
| EEFLENPWKDRTKAE | 271 | Q8N5F7 | |
| RKDVVDEKQPWVYLN | 296 | Q96FA3 | |
| RKLPWQDQEVKDYVI | 796 | Q9HAU5 | |
| EKKYSPCAWEVVRAE | 156 | P05013 | |
| VIPSEYWVEEKEEKQ | 341 | Q9UHC7 | |
| VWREDIPVNYMKELE | 391 | P06865 | |
| RDLYQEWKEKVPEAK | 756 | Q9H1H9 | |
| ESIKAWRPKELVLYE | 71 | Q5ST30 | |
| FQNVKEEWVPELKEY | 96 | P17081 | |
| VIYVPLTDKEKQWSR | 211 | P22061 | |
| LEADIREEKTSWKYQ | 161 | Q9BYJ4 | |
| LQKVEVEYETLPGWK | 396 | Q8N142 | |
| KRTYWPDLDAKIREA | 356 | Q8N7P1 | |
| YRRGEEWDPQKAEEK | 121 | O75391 | |
| EKEPEVLQDSLDRWY | 1141 | Q5TAG4 | |
| KKIISEEHWYLDLPE | 36 | Q99547 | |
| DWIFTIREKDPKNLE | 336 | Q9Y6E0 | |
| TYRIDDVDWNKTPKD | 426 | Q8TC59 | |
| LDPVYREEEESLKDW | 771 | A6NCM1 | |
| REEEESLKDWYFKTP | 776 | A6NCM1 | |
| INRKEVVEEKQPWAY | 296 | Q9HAT8 | |
| WAKYVDEKDVAKPSE | 196 | O60508 | |
| VQDLIRDYLEEGKKW | 66 | Q7Z443 | |
| ITLPKDKVWQKDEEY | 576 | Q7Z443 | |
| FVPDEQKDEKYWTRR | 226 | Q10587 | |
| IAKDPRYEKRWLDTL | 206 | Q9NY99 | |
| YDEKIDIWKIPDISS | 276 | Q9H5K3 | |
| LLEKREKTNFDPAEW | 46 | Q15506 | |
| EKKYSPCAWEVVRAE | 156 | P05014 | |
| FKVLPQEAEEERWYL | 171 | Q14849 | |
| ETEYKFEWQKGAPRE | 91 | Q86X95 | |
| PSLDKYAEERWEVVL | 146 | Q92759 | |
| KEYVEPELHINDLWR | 381 | Q7KZ85 | |
| EYNAPWKERVELIEK | 146 | Q5EBN2 | |
| AAEKRDPDEWRLEKY | 21 | Q9NZ43 | |
| QWKLLDEDEKRPFVE | 86 | O60248 | |
| ADILPANYVVKDRWK | 21 | Q5TCY1 | |
| EKVSALYKNPREWTR | 786 | P11217 | |
| EIPDDLKQLYKTVWE | 671 | P23921 | |
| KDIQHWESLKPEERY | 111 | P31350 | |
| TEKEKEIYRWPARES | 2661 | Q15413 | |
| EIDKKRSEIPCYWEN | 56 | O75152 | |
| PWRITDNELELYKTK | 1131 | P55011 | |
| APSIVWYKDERLLEE | 706 | P35916 | |
| DEEWQSEVLKYKPGR | 196 | P58340 | |
| EERPKQYSWDQREKV | 21 | O75695 | |
| EEEPWKRKVDEATFV | 156 | Q7Z340 | |
| PAKYSDIKSEDERWK | 1146 | O15014 | |
| RIYPDSIQELEVWKK | 201 | O60809 | |
| PWVKEVRKINDQYIA | 551 | Q9H0V1 | |
| WEDNLKDPKYVRDSK | 261 | Q99986 | |
| EEEESELGYIPKSKW | 2031 | P49750 | |
| EIDKKRSEIPCYWEN | 56 | A0A1B0GTU1 | |
| QKWEAEPVYVQRAKA | 166 | P25311 | |
| WYEKIAQEDPEKQRK | 1751 | O43149 | |
| IKRPAYWRTESEEEE | 816 | Q9UPP1 | |
| EEWKCLDPVQKALYR | 21 | Q5HY98 | |
| LTLWKKEEQEEPYVS | 121 | Q6PP77 | |
| KKWEDSETPKQNYRD | 646 | P31629 | |
| IWYKPVREDEESNKD | 1396 | Q14669 | |
| EGWLKEIYPEKRFAQ | 1141 | O15016 | |
| YAVEILTWEKESELP | 201 | Q8IWV8 | |
| WKLLSEAEKRPYIDE | 46 | O95416 | |
| KSPYRKQDPDTWENE | 171 | Q92995 | |
| EIYPRVSKILKEEWS | 276 | Q8IWR1 | |
| PRVEYTAEEIATWKE | 251 | P07101 | |
| ENISIPKYREVWDKD | 3931 | P20929 | |
| SGEILDDIKYRKDWN | 4171 | P20929 | |
| LIRKDYLEEPEKTQW | 481 | Q9NQS3 |